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In the mammalian cochlea, acoustic information is carried to the brain by the 
predominant (95%) large diameter, myelinated type I afferents, each of which is 
postsynaptic to a single inner hair cell.  The remaining thin, unmyelinated type II 
afferents extend hundreds of microns along the cochlear duct to contact many outer 
hair cells. Despite this extensive arbor, type II afferents are weakly activated by 
outer hair cell transmitter release, and are insensitive to sound.  Their function has 
been mysterious for decades due to their scarcity and lack of specific genetic 
markers. Intriguingly, type II afferents remain intact in damaged regions of the 
cochlea while outer hair cells and type I afferents are damaged by noise exposure.  
In this thesis, using whole-cell patch clamp recordings directly from the dendrites of 
type II afferents, we found that the weak synaptic transmission is mediated by 
GluA2 containing AMPA receptors. In contrast, ATP released from the damaged 
cochlea more potently activates type II afferents. We show that type II afferents are 
strongly depolarized when outer hair cells are damaged.  This response depends on 
both ionotropic (P2X) and metabotropic (P2Y) purinergic receptors, binding ATP 
released from nearby supporting cells in response to hair cell damage.  Selective 
activation of P2Y receptors increased type II afferent excitability by the closure of 
KCNQ-type potassium channels, a potential mechanism for the painful 
hypersensitivity that can accompany hearing loss.  Exposure to the KCNQ channel 
activator retigabine suppressed the type II fiber’s response to hair cell damage.  
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Type II afferents may be the cochlea’s nociceptors, prompting avoidance of further 
damage to the irreparable inner ear. 
 
Thesis advisors: Paul A. Fuchs, Ph.D. and Elisabeth Glowatzki, Ph.D. 
Thesis readers: Paul A. Fuchs, Ph.D. and Michael J. Caterina, Ph.D. 
Thesis Committee:  
Michael J. Caterina, Ph.D. (Chair)  
Richard L. Huganir, Ph.D. 


















First and foremost, I would like to thank my thesis advisors Paul and Elisabeth, 
for making my PhD training such a great experience. I was fortunate to be able to work 
with them and received their tremendous support, guidance and encouragement over the 
years. This project tackles an important question in the auditory field, but requires a lot of 
persistence and patience due to the difficulty in the recording technique. Paul and 
Elisabeth were always there to help and prioritize the training of their students. I still 
remember in the early days, Elisabeth showed me how to pull a patch electrode; Paul sit 
next to me to teach me the fundamentals of the experiments, and cheered with me upon 
my first successful recording on type II afferent. As the project moved forward, I was 
given a lot of freedom to become an independent researcher, explore different directions 
and design the experiments, while Paul and Elisabeth were always available to give 
advice, from the interpretation of the data to big picture of my thesis. Their enthusiasm 
and devotion to science have influenced me in many ways and were indispensable for my 
scientific development.  
I would like to thank my thesis committee members – Michael Caterina, Richard 
Huganir and King-Wai Yau for giving me invaluable advice both through thesis 
committee meetings and personal communications. My experience in King’s lab gave me 
great influence and I was very fortunate to get King’s advice, both scientifically and 
about personal life. Mike had been my pre-thesis advisor and the conversation with him 
was always exciting and inspiring. I am also very lucky to be among a collaborative and 
supportive environment of Fuchs and Glowatzki lab. I would like to thank all the present 
v 
 
and past members of the lab who are my great colleagues and friends. My special thanks 
to Catherine Weisz, a previous student of Paul and Elisabeth who pioneered the study of 
type II afferents, for sharing with me a lot of her experience and giving me tremendous 
help.  
During my graduate study, I learned a great deal from interactions with people in 
the Department of Neuroscience and the Center for Hearing and Balance, and I hope to 
thank the faculty and researchers here for creating such an inspiring environment. I would 
like to thank Dwight Bergles, as well as Yingxin Zhang, Travis Babola and Han-Chin 
Wang in his lab for sharing their expertise and being supportive for my work. I had a 
great experience in collaborating with Michael Deans and learned more aspects of 
auditory research with him. Craig Montell allowed me to rotate in his lab and introduced 
me into the sensory biology field. I also hope to thank Xinzhong Dong for giving me 
great suggestions, and Yin Liu, Yuejin Li and Haoran Wang, for your encouragement and 
advice on my career. 
Moreover, I would like to thank my parents for their enduring love and support. 
You set great examples of a strong work ethic, and devoted to create a happy and 
nurturing environment for me that I could hardly repay. I would like to thank my husband 
Kai Liu, who I met here during my PhD study and has been my biggest support. Finally, I 
would like to thank all my friends that make my life here an unforgettable experience, 
and my old friends in China who always send their encouragement and good wishes. It is 




Table of Contents 
Title Page i 
Abstract ii 
Acknowledgement iv 
Table of Contents vi 
List of Tables ix 
List of Figures ix 
List of Abbreviations xiv 
  
Background 1 
1. Morphology of type II cochlear afferents 1 
1.1 Basic structure of the auditory end organ 1 
1.2 Type II neurons in the spiral ganglion 3 
1.3 Peripheral process of  type II neurons 5 
1.4 Central projections of type II neurons 10 
1.5 Labeling of type II afferents 12 
2. Synaptic transfer at OHC - type II afferent synapses 14 
3. Purinergic signaling and function in the cochlea 21 
3.1 General properties of purinergic receptors 21 
3.2 Purinergic receptor expression and function in the cochlea 26 
3.3 Purinergic signaling involved in acoustic damage 30 
4. Hypersensitivity in pain and auditory pathologies 36 
vii 
 
4.1 Purinergic signaling and pain 36 
4.2 KCNQ channels and neuronal excitability regulation 38 
4.3 Hypersensitivity in tinnitus and hyperacusis 43 





Chapter 1: Morphology of type II cochlear afferents 55 
1.1 General properties of peripheral innervation 56 
1.2 Synaptic regions of type II afferents 70 
  
Chapter 2: Postsynaptic receptors of type II afferents 78 
2.1 Type II afferent innervation and synaptic markers 79 
2.2 AMPA receptors mediate OHC-type II synaptic transmission 89 
2.3 Acetylcholine responses of type II afferents 92 
  
Chapter 3: Purinergic signaling in type II afferents 96 
3.1 Characterization of the ionotropic P2X receptors 97 
3.2 Characterization of the metabotropic P2Y receptors 100 
3.3 P2Y receptor activation closes KCNQ potassium channels 104 
  
Chapter 4: Damage induced responses in type II afferents 109 
viii 
 
4.1 Outer hair cell damage activates type II afferents 109 
4.2 ATP from supporting cells contributes to the damage induced response 112 
4.3 Characterization of other components mediating type II afferents’ response to 
damage 
113 
4.4 Hypersensitivity of type II afferents during damage 116 
4.5 Calcium imaging on type II afferents using a cultured preparation 118 
  
Chapter 5: Discussion and Future work 122 
5.1 Synaptic structure of OHC-type II afferent synapses 122 
5.2 Type II afferents as nociceptive fibers 125 












List of Tables  
Background  
Table B1. Compounds acting as gonists for P2Y receptor subtypes. 24 
Results  
Table 1.1.1. Morphological Analysis of eight single arbor type II afferents. 61 
Table 1.1.2. Morphological Analysis of seven multiple arbor type II afferents. 68 
 
List of Figures  
Background  
Figure B1. Schematic illustration of afferent innervation in a cross section of the 
organ of Corti. 
3 
Figure B2. Somata of type I and type II neurons under light microscopy.  4 
Figure B3. Drawing of type I and type II afferents innervation in a whole-mount 
cochlea preparation. 
7 
Figure B4. Difference of type II afferents’ morphology in the apical, middle, and 
basal turn of the cochlea. 
8 
Figure B5. Schematic drawing of central innervation patterns of type I and type II 
afferents. 
12 
Figure B6. Ultrastructural image of ribbon synapses of IHC and OHC, from apical 
turn cochlea of P9 rats. 
16 
Figure B7. Synaptic transmission from OHC to type II afferents is likely mediated 18 
x 
 
by AMPA receptors.  
Figure B8. Kainate receptors GluK2 and GluK5 expression in OHC region of adult 
rat cochlea. 
20 
Figure B9. Stereoview of the homotrimeric P2X4 receptor structure. 23 
Figure B10. P2Y receptor subtypes and second messenger – mediated signaling 
pathways. 
24 
Figure B11. Mechanism underlies spontaneous activity in developing cochlea. 30 
Figure B12. Noise exposure damages OHCs 31 
Figure B13. Cochlear structures that are prone to damage and death over acoustic 
overstimulation.  
32 
Figure B14. A regenerative calcium wave triggered by ablation of a single hair 
cell. 
34 
Figure B15. P2X2 receptors are expressed in the cells lining the endolymphatic 
compartment in the mouse cochlea. 
35 
Figure B16. Physiological properties of KCNQ channels. 40 
Figure B17. Enhancing or blocking KCNQ channels affect excitability of 




Figure 1.1.1. Currents evoked by voltage steps in type II afferents. 57 
Figure 1.1.2. Whole-mount view of a biocytin-filled type II spiral ganglion neuron 
in the apical turn of P8 rat cochlea. 
60 




Figure 1.1.4. A single arbor type II afferents in the apical turn of young rat 
cochlea. 
63 
Figure 1.1.5. A multiple arbor type II afferents in the apical turn of young rat 
cochlea. 
65 
Figure 1.1.6. A multiple arbor type II afferents branched at the radial portion. 66 
Figure 1.1.7. A cochlear tissue with two labeled fibers – one single arbor type II 
afferents and one multiple arbor type II afferents projecting bi-directionally. 
67 
Figure 1.1.8.The only 2 out of 15 labeled fibers showing synaptic branches on 
multiple arbors. 
67 
Figure 1.1.9. Somata of six different type II neurons in the apical coil of young 
rats, showing peudounipolar or bipolar morphology. 
69 
Figure 1.2.1. Higher magnification of synaptic branches. 71 
Figure 1.2.2. A type II afferent gave off short branches as it crossed the tunnel of 
Corti. 
72 
Figure 1.2.3. Differential synaptic regions of two neighboring type II afferents. 73 
Figure 1.2.4. Morphological features plotted against the location of the type II 
afferents, measure by the distance from apex to their turning point. 
75 
Figure 2.1.1. Maximum intensity projections of confocal z-stacks of the medial 
region of the organ of Corti from an adult rat viewed from the endolymphatic 
surface including 24 adjacent OHCs and 5 IHCs.   
80 
Figure 2.1.2. Confocal z-stack of the OHCs of the medial region of the organ of 




Figure 2.1.3. Single type II fibers with intracellular labeling.   88 
Figure 2.2.1. AMPA receptors mediate the synaptic transmission from OHC to 
type II afferents. 
91 
Figure 2.3.1. Small ACh responses recorded in type II afferents from a P9 rat. 93 
Figure 3.1.1. ATP evoked inward current and depolarization in type II afferents. 98 
Figure 3.1.2. I-V relation of ATP response revealed by voltage ramp in voltage 
clamp recordings. 
99 
Figure 3.2.1. UTP induced inward current and depolarization in type II afferents. 100 




Figure 3.2.3. Low concentration of ATP preferentially activates ‘P2Y-like’ ramp 
currents. 
104 
Figure 3.3.1. KCNQ channels were closed upon P2Y receptor activation and 
regulated excitability of type II afferents. 
106 
Figure 4.1.1. The experimental preparation to study type II afferents’ response to 
damage. 
110 
Figure 4.1.2. ATP contributes to cell damage-induced response. 111 
Figure 4.2.1. OHC damage induced response was blocked by PPADS. 112 
Figure 4.2.2. Connexin hemichannel blocker reduced the slow component of 
damage induced response. 
113 
Figure 4.3.1. Damage-induced responses of type II afferents were insensitive to 




Figure 4.3.2. Potassium ions contribute to the peak damage-induced current. 116 
Figure 4.4.1. Type II afferents might become more excitable during OHC damage. 117 
Figure 4.4.2. The KCNQ channel activator retigabine reversibly prevented the 
response of type II afferents to OHC ablation. 
118 

















List of Abbreviations 
ABR auditory brainstem response 
ACh Acetylcholine 
AMPA α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid 
cAMP cyclic adenosine monophosphate 
CtBP2 C-terminal binding protein 2 
DAG Diacylglycerol 
DFNA2 deafness autosomal dominant autosomal locus 2 
DPOAE distortion product otoacoustic emission 
DREADDs designer receptors exclusively activated by designer drugs 
DRG dorsal root ganglion 
EM electron microscopy 
E-NPP ecto-nucleotide pyrophosphatase/phosphodiesterase 
E-NTPDase ecto-nucleoside triphosphate diphosphohydrolase 
EP endolymphatic potential 
EPSC Excitatory postsynaptic current 
EPSP Excitatory postsynaptic potential 
GABA γ-aminobutyric  acid 
GIRK G protein-coupled inward rectifiers K
+ 
channels 
GPCR G protein coupled receptor 
HRP horseradish peroxidase 
IHC inner hair cell 
xv 
 
IP3 inositol triphosphate 
KCNQ potassium voltage-gated channel subfamily Q 
MOC efferent medial olivocochlear efferent 
NF200 200 kDa  neurofilament protein 
NMDA N-methyl-D-aspartate 
OHC outer hair cell 
OSF outer spiral fiber 
PIP2 phosphatidylinositol 4,5-bisphosphate 
PLC phospholipase C 
PPADS pyridoxalphosphate-6-azophenyl-2′,4′-disulfonic acid 
SGN spiral ganglion neuron 
TMEM16A transmembrane protein 16A 











1. Morphology of type II cochlear afferents 
1.1 Basic structure of the auditory end organ 
The sense of hearing starts in the ear. Sound consists of compression and 
rarefaction of air, and travels in the form of pressure waves through the external ear canal.  
The resulting vibration of the tympanic membrane is transferred to the motion of fluids in 
the snail-shaped cochlea through the three middle ear bones. This fluid movement 
vibrates the basilar membrane in the inner ear, where the auditory sensory epithelium – 
the organ of Corti - is situated.  
The organ of Corti is the site of sound transduction in the cochlea, a beautiful and 
highly organized structure consisting of sensory cells and supporting cells. The organ of 
Corti contains one row of inner hair cells (IHCs) and three rows of outer hair cells 
(OHCs), serving as the receptors of the auditory system. These receptor cells are covered 
by a cantilevered gelatinous structure called the tectorial membrane. When sound strikes 
the eardrum and causes a traveling wave along the basilar membrane, a shearing force is 
created between the tectorial membrane and hair cells, bending hair cell bundles and 
gating the cation permeable mechanotransduction channels for sound transduction. 
Postsynaptic to the hair cells are the cochlear afferents that carry information from the 
auditory periphery to the brain. The mammalian cochlea is innervated by two classes of 
cochlear afferents – the majority population (~90 – 95 %) consists of type I afferents that 
contact IHCs and the minority population includes type II afferents that innervate the 
OHC region (Figure B1). Depolarization of IHCs triggers Ca
2+
-dependent release of 
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glutamate from a ribbon synapse, which in turn activates the postsynaptic type I afferents 
(Glowatzki and Fuchs, 2002; Goutman and Glowatzki, 2007; Grant et al., 2010),  Each 
type I afferent projects to a single IHC, whereas each IHC contacts on average 20-30 type 
I afferents. The IHC – type I synapse encodes the timing, intensity and frequency 
selectivity of sound information. Sound timing and intensity are encoded by the firing 
rates of type I afferents as a result of a related pattern of synaptic transmission from inner 
hair cells (Fuchs, 2005; Fuchs and Glowatzki, 2015; Moser et al., 2006). Frequency 
representation is determined by the position of the sensory neurons, as a consequence of 
‘tonotopy’ – that sound vibrates the basilar membrane in a frequency – specific manner. 
High frequency sound activates the sensory neurons at the base of the cochlea and low 
frequency sound activates the apical neurons. Type I afferents project directly to the hair 
cells corresponding to their characteristic frequency – a frequency to which they are most 
sensitive, thereby forming a tonotopic array along the cochlea (Liberman, 1982). 
The remaining 5 – 10 % of cochlear afferents are small-caliber, unmyelinated 
type II afferents. Each of them sends a long peripheral process and contacts multiple hair 
cells, receiving weak synaptic transmission. Current understanding about their 




Figure B1. Schematic illustration of afferent innervation in a cross section of the organ 
of Corti. RF: a radial fiber as an example of a type I afferent contacts a single IHC. OSF: 
an outer spiral fiber (type II afferent) travel on the floor of the tunnel of Corti, and then 
rise to contact OHCs. Efferents were not illustrated in this scheme (Simmons and 
Liberman, 1988a). 
 
1.2 Type II neurons in the spiral ganglion 
The somata of type I and type II cochlear afferents are named type I and type II 
spiral ganglion neurons (SGNs). They both reside in Rosenthal’s canal (also called the 
spiral canal) of the cochlea, a section of the bony labyrinth.  Compared to type I neurons, 
type II neurons are smaller in diameter and make up 5-10% of SGNs. Their somata were 
found in the more peripheral regions of the spiral ganglion (Berglund and Ryugo, 1987; 
Brown, 1987b). The cytoplasm of type II neurons was found to be more filamentous, 
showing fewer cytoplasmic organelles. This is reflected by basic stains and 
immunohistochemistry. With Nissl staining which primarily labels endoplasmic 
reticulum and the nucleus, type I neurons demonstrate denser intracellular Nissl bodies 
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than do type II afferents. On the other hand, when cytoskeletal elements were examined, 
type II afferents were more intensely stained, revealed by silver stains as well as 
antibodies against neurofilament 200 kDa (NF200) (Berglund and Ryugo, 1986; 
Berglund and Ryugo, 1991) and the intermediate filament protein peripherin (Hafidi, 
1998; Hafidi et al., 1993). Type II neurons are bipolar or pseudomonopolar, branched to 
send one peripheral process toward the organ of Corti and one central process to the 
cochlear nucleus in the brainstem. The peripheral and central processes of type II neurons 
are roughly equal in diameter, in contrast to the type I neurons where a thinner caliber 
peripheral branch is found in many species (Berglund and Ryugo, 1986; Kiang et al., 
1982). 
 
Figure B2. Somata of type I and type II neurons under light microscopy. Top: Cresyl 
violet staining showed more prominent Nissl substance in the slightly larger, type I 
neurons. Bottom: Protargol staining on the same cells after cresyl violet washed out. The 




1.3. Peripheral process of type II neurons 
Type II afferents are unmyelinated and have a smaller diameter than type I 
afferents (Bernard and Spoendlin, 1973; Perkins and Morest, 1975; Romand and Romand, 
1987; Romand and Romand, 1984; Spoendlin, 1971a). The radial processes of type II 
afferents project together with those of type I afferents toward the organ of Corti. Each 
type I projection terminates at the inner hair cell region, forming a synapse with a single 
inner hair cell. Type II afferents project past the inner hair cells, cross the tunnel of Corti 
and travel radially on its floor. After reaching the outer hair cell region, the fibers make a 
right angle turn towards the base of the cochlea, which represents higher frequencies. 
These are the spiral processes of type II afferents, also called outer spiral fibers (OSFs) 
according to their position in the cochlea. The spiral processes almost always turn toward 
the base and travel for hundreds of microns along the outer hair cell region (Berglund and 
Ryugo, 1987; Brown, 1987b; Ginzberg and Morest, 1983; Ginzberg and Morest, 1984; 
Perkins and Morest, 1975; Simmons and Liberman, 1988b), with the exception of the 
very apical fibers near the helicotrema which were identified as bi-directional and can 
project both apicalward and basalward (Perkins and Morest, 1975). The initial part of the 
spiral process usually stays far below the outer hair cells, and runs under the supporting 
cells (Deiters’ cells) for distances up to 0.5 mm. Then the process gradually risees to the 
base of the outer hair cells, extending a terminal portion commonly around 100 – 200 µm, 
which is characterized by 10 – 20 synaptic branches contacting the sides and bases of 
OHCs. Angular enlargements of the spiral fibers were also observed, possibly serving as 
en passant synapses (Brown, 1987a; Ginzberg and Morest, 1983; Perkins and Morest, 
1975; Simmons and Liberman, 1988b). The length of the entire spiral process reaches 
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670 µm in rat (Perkins and Morest, 1975) and up to 1200 µm in cat (Simmons and 
Liberman, 1988a; Spoendlin, 1969). Electron microscopic analysis revealed about 28 
afferent terminals innervating apical OHCs and about 7.75 terminals per OHC at the base 
in guinea pig (Hashimoto and Kimura, 1988). In cats, an average of 6-8 afferent terminals 
were found on each OHC base (Ginzberg and Morest, 1984). In some cases, the major 
shaft of the process could branch and contact multiple rows of outer hair cells. Only 3 out 
of 34 type II afferents in adult guinea pig were found to contact multiple rows (Brown, 
1987a), whereas 23 of 51 fibers contacted two rows and 8 of 51 fibers contacted three 
rows in young cats (Perkins and Morest, 1975), and 15 of 85 fibers contacted multiple 
rows in adult cats (Simmons and Liberman, 1988a). It is unknown if such differences 
arise from the age or species of the animals. Among the multiple-row type II afferents in 
adult cats, more than 50% of their synaptic branches innervate only to a single row of 
OHCs. It was also reported that basal type II afferents tend to innervate only one row of 




Figure B3. Drawing of type I and type II afferents innervation in a whole-mount cochlea 
preparation. Showing the spiral ganglion, one row of IHCs and three row of 
OHCs.(Berglund and Ryugo, 1987) 
 
Certain morphological features of type II afferents might be related to the specific 
row of OHCs contacted. In cat cochlea, more type II afferents seem to contact the first 
row of OHCs (44% to 48% of reconstructed fibers examined in two samples), and similar 
numbers of afferents contact row-2 and row-3 (24% - 31%). Row-3 type II afferents have 
more synaptic branches and longer terminal regions (Simmons and Liberman, 1988a). 
Similar observations in guinea pig cochlea showed that row-3 type II afferents are longer 
in length, with larger terminal regions and more synaptic branches. The number of OHCs 
contacted by row-3 type II afferents could be 2 – 3 times more than that of row-1 type II 
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afferents, according to 34 fibers reconstructed from horseradish peroxidase (HRP) 
staining (Brown, 1987a). 
 
Figure B4. Difference of type II afferents’ morphology in the apical, middle, and basal 
turn of the cochlea. Schematic innervation of the three rows of OHCs were illustrated 
under the fibers, with the blackened dots representing OHC contacts. (Simmons and 
Liberman, 1988a) 
 
An apical-basal difference of type II afferents’ morphology was also reported 
(Figure B3). The length of type II afferents as well as the length of their terminal regions 
were found to be maximum in the apical portion of the middle turn, with decreasing 
length of both when moving to either apical or basal portions of cat cochlea. Apical type 
II afferents have larger diameters, about 0.8 µm, while those of basal type II afferents 
averaged about 0.2 µm.  The apical type II afferents seem to have both en passant and 
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terminal synapses whereas the basal type II afferents have more terminal branches and 
few en passant synapses (Simmons and Liberman, 1988a). Up to all three rows of OHCs 
can be innervated by a single apical type II afferent, which is rarely seen at the basal part 
of the cochlea. More elaborate patterns of innervation were observed in the apical but not 
the basal type II afferents (Brown, 1987a; Fechner et al., 2001; Simmons and Liberman, 
1988a). 
Besides outer hair cells, several morphological studies suggest that type II 
afferents may contact other cell types. Collaterals occasionally appeared in the portion of 
type II afferents that passes inner hair cells (Perkins and Morest, 1975). But it was not 
certain if these are definite and functional synaptic structures. Supporting cells in the 
outer hair cell region, including Deiters’ and Hensen’s cells, are proposed to form 
synapses with type II afferents. This is only observed in the apical half of the cochlea but 
not the basal half (Burgess et al., 1997; Fechner et al., 2001). Electron microscopic 
analysis showed synaptic specializations between these supporting cells and adjacent 
fibers presumed to be type II afferents, because these fibers were negative for 
acetylcholinesterase and densely stained for neurofilaments (Burgess et al., 1997). In the 
apical part of the guinea pig cochlea, type II afferents were found to send branches onto 
Deiters’ and Hensen’s cells (Fechner et al., 1998; Fechner et al., 2001). These putative 
supporting cell – type II synapses have not been functionally characterized. Additional 
ultrastructural studies also revealed efferent to type II afferent synapses (Nadol, 1983; 
Thiers et al., 2002) and reciprocal synapses between OHC and type II afferents (Francis 
and Nadol, 1993; Nadol, 1981; Thiers et al., 2002; Thiers et al., 2008). These synapses 
were identified through the observation of small numbers of vesicles accumulating close 
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to the afferent’s cell membrane, as well as some asymmetric membrane thickenings and a 
synaptic cistern in the hair cell. Whether these are functional synapses and what role they 
play is unknown. 
 
1.4. Central projections of type II neurons 
The central processes of cochlear afferents, including those of both type I and 
type II afferents, are bundled together to form the auditory nerve. They enter the cochlear 
nucleus as the root branch, and then the axons of both type I and type II afferents 
bifurcate (Figure B5) (Brown et al., 1988a; Fekete et al., 1984; Pillsbury, 1996). The 
position of the bifurcation is arranged in a tonotopic manner, which reflects the fiber’s 
position in the cochlea (Liberman, 1982). After bifurcation, the ascending branch of the 
axon projects to the anteroventral cochlear nucleus (AVCN), and the descending branch 
passes through the posteroventral cochlear nucleus (PVCN) and terminates in the dorsal 
cochlear nucleus (DCN). Similar to the position of bifurcation, the ascending and 
descending branches are also arranged tonotopically, with higher frequency fibers  
positioned more dorsally (Nayagam et al., 2011). A variety of postsynaptic targets of type 
I afferents have been identified in the magnocellular core of the cochlear nucleus which 
contains large neurons that project in turn to the higher centers of the auditory pathway 
(Brawer and Morest, 1975; Rouiller et al., 1986).  Collaterals from these axons form en 
passant swellings (which may or may not be synapses) and terminal branches which are 
characterized to be the sites of synapses (Fekete et al., 1984; Ryugo and Sento, 1991). 
These type I axon terminals were found to be restricted to the core of the cochlear 
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nucleus (Berglund and Brown, 1994; Brown et al., 1988a; Brown and Ledwith, 1990). In 
contrast, the ellipsoidal swellings present on type II afferents within the magnocellular 
regions do not seem to form synapses (Berglund et al., 1996; Ryugo and Sento, 1991). 
However, type II afferents extend their axon beyond the core regions of cochlear nucleus, 
with addition termination at a bordering region called the granule-cell lamina (Figure B5) 
(Benson and Brown, 2004; Berglund and Brown, 1994; Hurd et al., 1999). Postsynaptic 
targets of type II afferents were identified by serial-section electron microscopy with type 
II afferent terminals labeled by HRP. Most of the targets were small dendrites from the 
“small cells” at the edge of granule cell layer. Axosomatic synaptic contacts on large 
cells were also observed. These large cells were presumed to be multipolar or globular 
bushy cells, but their identity was not confirmed anatomically (Benson and Brown, 2004).  
Another study suggests that type II afferents contact local interneurons in the granule cell 
layer, including small stellate and mitt cells but perhaps not granule cells (Hurd et al., 
1999). In addition to the type II afferent innervation, the granule cell layer also receives a 
wide variety of auditory descending inputs and non-auditory projections, such as 
somatosensory input (Paloff and Usunoff, 1992; Shore and Zhou, 2006; Wright and 
Ryugo, 1996; Zhan and Ryugo, 2007) and collaterals from olivocochlear efferents that 
innervate OHCs (Benson and Brown, 1990; Brown et al., 1988b; Brown et al., 1991). 
Therefore, the granule cell layer is considered an integrative zone, where convergence of 
information from different sources including type II afferents might occur. The higher-





Figure B5. Schematic drawing of central innervation patterns of type I and type II 
afferents. Modified from Brown et al., 1988. 
 
1.5 Labeling of type II afferents 
Besides their small population size and difficulty in recording type II afferents, 
the lack of specific genetic marker for type II afferents has also hindered progress to 
isolate the function of these neurons. Neurofilament proteins are present in both type I 
and type II afferents, proposed to have a role in maintaining the structural integrity and 
axon growth during development (Barclay et al., 2010; Barclay et al., 2011). These 
proteins have been examined for their potential as specific markers. An antibody (RT-97) 
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against the heavy (200 kDa) chain of neurofilament – NF-200 - seems to label type II 
neurons. Such labeling was found to be highly dependent on the phosphorylation state of 
the heavy neurofilament in type II neurons, and only the somata were labeled, without 
confirmation by dendritic projection pattern (Berglund and Ryugo, 1986; Berglund and 
Ryugo, 1991). Another study reported that a more general neurofilament antibody 
(polyclonal anti-NF200) could label both type I and type II afferents (McLean et al., 
2009). The same study showed that antibody against a sodium-potassium ATPase 
NKAα3 labels the type I afferents under the IHCs and medial olivocochlear efferents in 
the outer hair cell regions, but not type II afferents. So far the most recognized type II 
‘marker’ protein is the type III intermediate filament protein peripherin. However, 
peripherin is expressed in both type I and type II afferents in early development. During 
the embryonic days, peripherin expression was found throughout the spiral ganglion. 
After P3, peripherin immunoreactivity was reduced in most of the spiral ganglion 
neurons. In adulthood, only a small population (roughly 8% of total SGNs) of peripherin 
positive neurons was seen that correspond numerically to the type II afferents (Hafidi et 
al., 1993), and such labeling was also observed in their peripheral and central processes 
(Hafidi, 1998). Another study suggests that as early as P6, peripherin expression is 
restricted to type II afferents, whereas TMRD (tetramethylrhodamine-conjugated 
dextran) labels a separate population of neurons representing type I afferents (Huang et 
al., 2007a).  The innervation pattern of type II afferents has been examined in a 
peripherin knockout mouse line (Lariviere et al., 2002). In neonatal ages (P1 and P7), 
type II afferent innervation in the outer hair cell regions was found to be normal, as  
revealed by the immunofluorescence of β-tubulin in the cochlea of peripherin null mouse 
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(Barclay et al., 2010). In the adult cochlea though, type II afferents were found missing 
when the same mouse line was examined, reflected by the loss of NF200 positive fibers 
in the outer hair cell regions and the loss of type II afferents terminals by EM analysis of 
3 OHCs (Froud et al., 2015). Peripherin might therefore be a good candidate for type II 
specific labeling. However, a conditional peripherin-CreER mouse line is more desirable, 
in order to eliminate the possible developmental influence on type I afferents due to its 
transient expression on all SGNs in embryonic and early postnatal days. 
 
2. Synaptic transfer at OHC – type II afferent synapses 
Each type II afferent is postsynaptic to multiple OHCs. However, limited numbers 
of in vivo single unit recordings revealed that these fibers are mostly likely insensitive to 
sound. Among the 11 recorded type II neurons reported by three papers, only one of them 
responded to intense broad band sound and even it was not anatomically confirmed 
(Brown, 1994; Robertson, 1984; Robertson et al., 1999). A breakthrough on this question 
has been made by whole-cell patch clamp recording from spiral processes of type II 
afferents, showing that type II afferents are excitable and receive synaptic inputs from 
multiple outer hair cells (Weisz et al., 2009; Weisz et al., 2012). The synaptic transfer is 
rather weak (Weisz et al., 2012), consistent with the hypothesis that type II afferents may 
only respond to loudest or even traumatic levels of sound that activate large numbers of 
presynaptic OHCs. 
Hair cell synaptic transmission is mediated by the ribbon synapse. This highly 
specialized synaptic structure contains a pre-synaptic electron dense body – ribbon, a 
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halo of vesicles tethered to the ribbon and voltage-gated calcium channels clustered and 
forming patches under it. Ribbon synapses were found in mammalian cochlear and 
vestibular hair cells as well as retinal photoreceptors and bipolar cells, although there are 
differences in the size and the organization of vesicles. Similar to inner hair cells, outer 
hair cells also contain ribbons, but with a smaller number (2-5 ribbons per OHC versus 
20-30 ribbons per IHC). More ribbons were found in immature OHCs in young animals, 
and there appears to be a developmental change in the expression of synaptic proteins 
(Beurg et al., 2008; Fujikawa et al., 2014; Siegel and Brownell, 1981). Electron 
microscopy studies identified ribbons associated with type II afferents terminals in guinea 
pig and chinchilla OHCs (Siegel and Brownell, 1981; Smith and Sjostrand, 1961). 
Anatomical differences among ribbons were found when the OHC ribbons were 
compared with IHC ribbons by ultrastructural studies (Figure B6). OHC ribbons have a 
slightly higher height to width ratio so that they are taller and narrower. A big cloud of 
vesicles was observed in young IHCs that extended several micrometers away from the 
ribbon, but not in OHCs. Close to the synaptic site, IHC ribbons have 2-3 times more 
nearby, tethered, and docked vesicles than do OHC ribbons (Weisz et al., 2012). 
Expression of the Cav1.3 L-type calcium channels has also been demonstrated in OHCs, 
responsible for the release of vesicles. They are found to co-localize with immunolabel 
for C-terminal binding protein 2 (CtBP2) – Ribeye, a protein component of the ribbon 
(Hafidi and Dulon, 2004; Knirsch et al., 2007; Michna et al., 2003). Although the calcium 
current in OHCs is smaller, the calcium current per ribbon is similar for OHC and IHC 
synapses (Knirsch et al., 2007). Calcium currents have been related to capacitance 
measurement of OHCs, providing evidence for synaptic vesicle exocytosis from likely 
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two distinctive vesicle pools (a readily releasable pool and a slowly releasable pool) in 
immature OHCs (Beurg et al., 2008). 
 
Figure B6. Ultrastructural image of ribbon synapses of IHC and OHC, from apical turn 
cochlea of P9 rats.(Fuchs and Glowatzki, 2015) 
 
These minor distinctions in ribbon structure and channel-coupling seem 
insufficient to explain the major differences in release efficiency between OHCs and 
IHCs. In young rats, each action potential in IHCs causes the release of 40-50 vesicles at 
a single synaptic contact (Beutner et al., 2001; Glowatzki and Fuchs, 2002). In sharp 
contrast, each action potential in OHCs has only one fourth probability to trigger single 
vesicular release at OHC synapses. Maybe the better organization of the IHC ribbon 
structure could account for more their effective transmission (Wittig and Parsons, 2008). 
Another possible explanation might be the smaller aggregation of calcium channels under 
outer hair cell ribbons – the patches thought to include voltage-gated calcium channels 
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are four times smaller in OHCs than in IHCs (Saito, 1990). Immunohistochemistry 
studies also found a lack of the vesicular glutamate transporter VGlut3 in OHC. VGlut3 
is used in IHC vesicles and is required for IHC synaptic transmission (Seal et al., 2008). 
It is unknown whether other vesicular glutamate transporter isoforms underlie OHC 
synaptic transmission.  
Like the IHC-type I synapse, synaptic transmission at the OHC – type II afferents 
synapse is also likely to be mediated by AMPA(α-amino-3-hydroxy-5-methyl-4-
isoxazole propionic acid)-type glutamate receptors. Whole-cell patch clamp recordings 
made directly from type II afferent spiral dendrites revealed typical fast excitatory 
postsynaptic currents (EPSCs) when OHCs were depolarized by high potassium solution. 
These EPSCs can be reversibly blocked by the AMPA receptor antagonist NBQX (Figure 
B7) (Weisz et al., 2009). However, this physiological evidence was not supported by the 
previous immunohistochemistry studies that examined the postsynaptic glutamate 
receptors expressed in the cochlea. Many studies have demonstrated puncta of GluA2/3 
antibody staining at the type I afferent terminals, but failed to label the postsynaptic 
receptor in type II afferents (Flores-Otero and Davis, 2011; Khimich et al., 2005; 
Liberman et al., 2011; Matsubara et al., 1999; Thiers et al., 2008). A recent study using 
antibody against only the GluA2 subunit revealed puncta of GluA2 receptors juxtaposed 
to Ribeye – a protein component of the ribbon. However the staining was observed in P8 
but not adult rat cochlea  (Huang et al., 2012). This immunohistochemistry study on 
mouse cochlea proposed development changes in synaptic markers expression, showing a 
synaptic refinement process. Excess CtBP2 and GluA2/3 puncta were found in the outer 
hair cell regions in newborn mice, from P0 to around P3/P6. After that, great reduction of 
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these immunostaining puncta was seen until the onset of hearing (P12). Although the 
study claimed the presence of GluA2/3 in adult mouse outer hair cell region, the labeling 
was rather weak and was found not associated with the presynaptic marker CtBP2, 
therefore it is still unclear if AMPARs participate in the OHC-type II synapse. 
 
Figure B7. Synaptic transmission from OHC to type II afferents is likely mediated by 
AMPA receptors. A. Receptive field map of OHC inputs onto eight different type II 
afferents. Red: functionally connected OHCs. Blue: OHCs showed no synaptic inputs to 
recorded type II afferents. White: OHCs have not been tested. Black: OHCs removed for 
type II afferents recordings. (Weisz et al., 2012). B. EPSCs triggered by OHC 
depolarization can be blocked by the AMPAR antagonist NBQX. (Weisz et al., 2009) 
 
On the other hand, two subtypes of kainate receptors – GluK2 and GluK5 have 
been shown to be consistently expressed in the OHC region in both young and adult rat 
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cochlea (Fujikawa et al., 2014). GluK2 was found juxtaposed to CtBP2 (the marker for 
presynaptic ribbon), whereas GluK5 was found associated with every puncta of the PSD-
93 (a postsynaptic density protein) that extends in a string – named “C-shape” in this 
work (Figure B8). Both GluK2 and GluK5 antibody labeling were also found in the 
medial efferent terminals and in the center of the OHC base (Fujikawa et al., 2014). 
Kainate receptor is another class of ionotropic glutamate receptor, less understood than 
AMPA and NMDA (N-methyl-D-aspartate) receptors. Current understandings about their 
function include that they could mediate some synaptic current at certain synapses; they 
potentially modulate synaptic transmission; and they support maturation of neural 
circuitry via an unconventional metabotropic pathway (Lerma and Marques, 2013). In 
native neurons, kainate receptor-mediated EPSCs are prominently slower in kinetics than 
AMPA receptor-mediated EPSCs (Castillo et al., 1997; Frerking et al., 1998; Vignes et 
al., 1998), due to the action of the auxiliary subunit Neto (Straub et al., 2011). The 
AMPA receptor antagonist NBQX used in the physiological study may also serve as 
competitive antagonist for kainate receptors (Kew and Kemp, 2005), leaving open the 
possibility for kainate receptor-mediated EPSCs in type II cochlear afferents. To resolve 
this discrepancy, a more optimized characterization of synaptic proteins by 
immunostaining, as well as pharmacological studies with more specific kainate or AMPA 




Figure B8. Kainate receptors GluK2 and GluK5 expression in OHC region of adult rat 
cochleae. Arrows in D and G point to postsynaptic densities thought to be on type II 
terminals, whereas the more bulky GluK2 or GluK5 labeled terminal are likely belong to 
the medial efferents. (Fujikawa et al., 2014) 
 
Intracellular recordings from type II afferents revealed weak synaptic activation 
of type II afferents by OHCs. Excitatory postsynaptic potentials (EPSPs) recorded from 
type II afferents were small (3.8±2.0 mV) compared with the depolarization needed to 
reach action potential threshold (~25 mV) (Weisz et al., 2009). Functional connections 
between OHC and type II afferents were mapped by recording from type II afferents 
while puffing high potassium solution to activate each individual OHC (Weisz et al., 
2012). Mapping of presynaptic OHCs yields an estimation of at least ten OHCs providing 
synaptic inputs to type II afferents. Taking into account the low release probability of 
OHC (average ~ 0.25) also measured in this set of experiments, it suggests that type II 
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afferents may fire action potentials only when the entire pool of presynaptic OHCs are 
activated and the EPSPs are able to summate. Dual electrode recordings from type II 
afferents demonstrated a length contact longer than the extent of their spiral process, 
therefore summation of EPSPs over the long synaptic input regions is possible (Weisz et 
al., 2014). In addition to the weak synaptic inputs onto type II afferents, large responses 
to ATP were recorded in type II afferents. ATP-induced responses include a synaptic 
component through activation of OHCs by ATP (Nakagawa et al., 1990), and a more 
prominent, slow current that seems to be a direct effect of ATP on type II afferents 
(Weisz et al., 2009). Therefore, ATP seems to be a more potent way to activate type II 
afferents than the weak synaptic transmission from OHCs. The types of ATP receptors 
and their functional implication remained to be determined. 
 
3. Purinergic signaling and function in the cochlea 
3.1 General properties of purinergic receptors 
Purinergic receptors are one of the most abundant receptors in the living organism. 
They are widely expressed in neurons and non-neural tissues, mediating cell-to-cell 
communication through synaptic transmission (as neurotransmitter or co-transmitter) or 
paracrine mechanisms (Abbracchio et al., 2009; Burnstock, 2009; Burnstock, 2013). 
They further divided in two families according to their endogenous agonists. A P1 
receptor family activated by adenosine is subdivided into four classes (A1, A2A, A2B and 
A3) and are all G-protein coupled receptors. A P2 receptor family (primarily sensing 
adenine and uracil tri- and dinucleotides) includes two classes of receptors – P2X and 
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P2Y receptors with distinctive molecular properties and agonist selectivity. All of these 
receptor subtypes were identified in the cochlea (Housley et al., 2009). 
The ionotropic P2X receptors are non-selective cation channels that open in 





(equal permeability), with significant permeability to Ca
2+
 (Egan and Khakh, 2004). They 
include seven subtypes (designated as P2X1 – P2X7, according to historical order of 
cloning) forming homomeric (P2X1-P2X5, and P2X7) or heteromeric (P2X1/2, P2X1/4, 
P2X1/5, P2X2/3, P2X2/6, P2X4/6 and P2X4/7) trimers (Guo et al., 2007; Nicke et al., 1998; 
North, 2002; Roberts et al., 2006). Hydropathy analysis and crystallography studies 
revealed that each subunit possesses two hydrophobic transmembrane spanning regions 
(TMRs), a large extracellular loop and intracellular NH2 and COOH termini (Figure B9) 
(Gonzales et al., 2009; Hattori and Gouaux, 2012; Kawate et al., 2009).  The subunit 
stoichiometry determines their differential ligand affinity and ligand-induced receptor 
desensitization kinetics. In general, most P2X receptors have an EC50 of 1-10µM ATP 
activation, except for the homomeric P2X7 which is less sensitive and activated at 100-
1000µM ATP concentrations (Junger, 2011). Once opened by ATP, P2X receptors could 
serve as a significant source of Ca
2+
 entry, being able to regulate neurotransmitter release 
(Sperlagh et al., 2007) and interact with many channels through Ca
2+
 signaling, including 
nicotinic acetylcholine receptors, GABAA receptors and NMDA receptors (Khakh et al., 




Figure B9. Stereoview of the homotrimeric P2X4 receptor structure. Modified from 
(Kawate et al., 2009). 
 
The other class of P2 receptors includes P2Y receptors that are seven-
transmembrane-spanning G-protein coupled receptors (GPCRs), forming homodimers or 
heterodimers (Figure B10). Among the eight P2Y receptors, P2Y1, P2Y2, P2Y4, P2Y6 
and P2Y11 use Gq/G11 to activate phospholipase C (PLC), and therefore robustly trigger 
inositol lipid signaling responses, including the production of diacylglycerol (DAG) and 
inositol triphosphate (IP3) which could trigger IP3-mediated mobilization of internal Ca
2+
 
stores and increased activity of protein kinase C. Activated Gαq may also promote Rho 
signaling through a guanine nucleotide exchange factor (p64 RhoGEF) (Lutz et al., 2005). 
The other subgroup of P2Y receptors, including P2Y12, P2Y13 and P2Y14, activate Gi 
and lead to Gαi-dependent inhibition of adenylyl cyclase and decreased levels of cyclic 
adenosine monophosphate (cAMP), regulating channels and protein kinases (Abbracchio 
et al., 2006). Because of their difference in amino acid sequence and molecular properties, 
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each P2Y receptor has a distinct pharmacological profile and is activated by different sets 
of adenine and uracil tri- and dinucleotides (Table B1) (von Kugelgen and Harden, 2011). 
UTP was found to activate P2Y2, P2Y4 and P2Y6 receptors. ATP could activate P2Y2, 
P2Y11, P2Y13 as well as rodent P2Y4 receptors. The EC50 for ATP activation is in the 
nano-molar range for P2Y2 and P2Y13 receptors, and is higher for rodent P2Y4 receptors 
(around 2 µM) and is highest for P2Y 11 receptors (around 17 µM) (Junger, 2011). 
  
Figure B10. P2Y receptor subtypes and second messenger – mediated signaling pathways. 
(von Kugelgen and Harden, 2011). 
 
Table B1. Compounds acting as gonists for P2Y receptor subtypes. Modified from (von 
Kugelgen and Harden, 2011). 
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ATP can be released from neurons and glia through multiple mechanisms. ATP 
was found to accumulate in secretory and synaptic vesicles, can be co-released with other 
neurotransmitters (e.g. GABA, glutamate and noradrenaline), and some evidence 
suggests the existence of ATP-only vesicles in the cortex and medial habenula (Pankratov 
et al., 2006; Pankratov et al., 2007). Despite the compelling evidence of vesicular release 
of ATP, it had been assumed that ATP could be released only from damaged or dying 
cells. But more evidence suggests that ATP can be released even from healthy cells under 
stress conditions, including mechanical stress, osmotic changes as well as hypoxia and 
stimulation of certain agents. Such mechanisms involve ATP exit through large-pore 
channels – connexin or pannexin hemichannels, plasmalemmal voltage-dependent anion 
channels and P2X7 receptors (Bodin and Burnstock, 2001; Lazarowski, 2012). It is not 
clear though whether other nucleotides (e.g. UTP, ADP and UDP) are released by similar 
mechanisms under physiological or pathological conditions. Once released, ATP 
undergoes rapid enzymatic degradation by ectonucleosidases (Yegutkin, 2008). In this 
way the lifetime of ATP is controlled and the action of ATP sensitive receptors is 
decreased. The products of enzymatic reaction could serve as ligands for additional 
purinergic receptors. For example, ATP can be degraded to ADP and AMP, through the 
action of E-NTPDases (ecto-nucleoside triphosphate diphosphohydrolases) and E-NPPs 
(ecto-nucleotide pyrophosphatase/phosphodiesterases), and further to adenosine by ecto-
5’-nucleotidases. Indeed, enzymatic breakdown generates the most recognized source of 
adenosine acting on the P1 receptors, although some subpopulations of neurons or 




3.2 Purinergic receptor expression and function in the cochlea 
Purinergic components are widely expressed in the neural and non-neural 
structures in the young and adult cochlea. P2X receptor mediated currents have been 
recorded from isolated inner and outer hair cells of the adult guinea pig (Housley et al., 
1999; Sugasawa et al., 1996). P2X2 receptors are expressed in hair cells and its 
expression pattern has been both anatomically and functionally localized to the apical 
surface and stereocilia (Housley et al., 1992; Housley et al., 1999; Housley et al., 1998; 
Jarlebark et al., 2000; Mockett et al., 1994; Yan et al., 2013). P2X receptor-mediated 
currents were recorded in isolated OHCs (Glowatzki et al., 1997). The current only 
appeared upon puffing ATP onto the apical surface but not upon local application of ATP 
to the basolateral sides of OHCs (Housley et al., 1992). This is further supported by 
calcium imaging studies. Focal application of ATP triggers Ca
2+
 entry first from the 
apical surface of the OHCs, and then a second surge of Ca
2+ 
signal was observed at the 
base which is proposed to be mediated by IP3 receptors on a specialized ER structure 
(known as Hensen’s body) in the hair cell (Mammano et al., 1999b). The role for these 
ATP-induced currents in OHCs is not clear. It has been reported that direct application 
ATP affected the electromotility of OHCs and reduced the gain of the cochlear amplifier 
(Zhao et al., 2005). However, another study found that ATP responses did not interfere 
with the electromotility of OHCs (Mammano et al., 1999b). Another proposal is that the 
nonselective conductance of P2X receptors may shunt K
+
 out of the endolymphatic 
compartment, being a protective mechanism against acoustic stress (see discussion in part 
3.3 of this Introduction). P2X7 receptors are expressed transiently in hair cells before 
postnatal day 6 but their function is unknown (Nikolic et al., 2003). Expression of P2Y1, 
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P2Y2 and P2Y4 receptors was found in the outer hair cells of guinea pig by 
immunolabeling (Mammano et al., 1999a; Szucs et al., 2004). However, these findings 
are confounded by the lack of UTP induced current in guinea pig outer hair cells 
(Housley et al., 1999). 
In spiral ganglion neurons, immunohistochemistry and in situ RT-PCR 
experiments have identified a variety of P2 receptors, including P2X3 receptors in early 
postnatal days and P2X2 and P2X7 as sustained expression throughout life (Huang et al., 
2005; Huang et al., 2007b; Nikolic et al., 2003; Salih et al., 1998). It has been proposed 
that the transient expression of P2X2/P2X3 receptors regulates neurite outgrowth during 
development. In early postnatal days, type I and type II afferents form excess innervation 
on both inner and outer hair cells followed by pruning and refinement of the mis-matched 
fibers to reach specific synaptic innervation patterns. The expression of P2X2/P2X3 
receptors was detected by quantitative singe cell RT-PCR. Activation of these receptors 
was proposed to inhibit neurite extension elicited by the neurotrophin BDNF and to 
contribute to the withdrawal phase of pruning (Greenwood et al., 2007). P2X2 has been 
localized to the postsynaptic specialization of the afferents under inner and outer hair 
cells by immunogold labeling (Housley et al., 1999), and was found to be expressed in 
the somata of spiral ganglion neurons (Salih et al., 1998). P2X7 receptor expression has 
been detected in the embryonic (E14–E18 days) and postnatal (P0–adult) rat cochlea 
using immunohistochemistry. Immunolabeling for P2X7 was detected in the spiral 
ganglion, efferent and afferent bundle that cross the tunnel of Corti, and synaptic regions 
beneath inner and outer hair cells (Nikolic et al., 2003). The metabotropic P2Y receptors 
have also been found to express in the spiral ganglion by immunolabeling, although type 
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I and type II neurons were not distinguished (Huang et al., 2010). Despite the findings of 
various P2 receptor expression in SGNs of which 95% are type I neurons, their response 
to ATP is rather small, according to direct recording from type I afferent boutons in an ex 
vivo preparation of young rat cochlea (Tritsch et al., 2007). A contradictory result comes 
from recordings on the soma of isolated SGN in neonatal rats (Ito and Dulon, 2002). The 
response of SGNs to 100µM ATP is big but variable (760 ± 530 pA, Vhold = -50 mV, n 
= 135) and ~77% of the cells displayed two components – a faster P2X-like conductance 
with a response latency of less than 50 ms, and a slower response (occurred over 1 s) that 
was attributed to P2Y receptors and with a reversal potential at 0 mV. Such discrepancy 
could have arisen from the differential distribution of receptors in dendrites versus 
somata, or the effect of mechanical and enzymatic treatment on the receptors during the 
cell isolation process. 
On the other hand, it is clear that type II afferents respond to ATP robustly at least 
in early postnatal days. Direct recording from type II afferents’ dendrites revealed large 
depolarizations induced by ATP, and action potentials were elicited in extracellular 
recordings during ATP application. These action potentials could be blocked by 
pyridoxalphosphate-6-azophenyl-2′,4′-disulfonic acid (PPADS), a P2X receptor 
antagonist that also partially blocks P2Y4 and P2Y6 receptors. After the onset of hearing, 
ATP responses of type II afferents persist but apparently become smaller (Weisz et al., 
2009). It is unknown whether both P2X and P2Y receptors mediate such responses and 
what might be the functional significance of P2 receptor mediated signaling in type II 
afferents. Only one study localized the P2X2 immunogold labeling at type II afferent 
terminals (Housley et al., 1999), providing a candidate receptor mediating the PPADS 
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sensitive response. P2Y2 receptors are expressed in a small subset of SGNs, labeling 
around 5% -10% of the total population and so consistent with type II afferents, but this 
study did not provide further evidence for the identity of these SGNs (Huang et al., 2010). 
Purinergic signaling is important for the development of synaptic connections in 
the auditory system. Before the onset of hearing, a transient pseudo-stratified epithelium, 
known as Kölliker’s organ is formed medial to the inner hair cells. The inner supporting 
cells of the Kölliker’s organ spontaneously release ATP and play a crucial role in 
generating periodic, high-frequency bursts of activity in the developing auditory pathway 
(Tritsch et al., 2010; Tritsch et al., 2007). This phenomenon involves ATP-induced ATP 
release, which activates the autoreceptor (P2Y receptor) on the inner supporting cells, 
thus triggering an increase in intracellular Ca
2+
. This in turn activates TMEM16A 




 channel, which not only expels Cl
−
, 
but also triggers efflux of K
+
 (as counter ions) and water (Figure B11) (Wang et al., 
2015). The rise in extracellular K
+
 depolarizes IHCs to trigger glutamate release, 
generating repetitive firing of type I afferents. ATP is indispensable for this process, 
because such effects can be blocked by the application of apyrase, an enzyme that 
hydrolyzes ATP (Tritsch et al., 2007). The repetitive firing of type I afferents stopped 
around the onset of hearing (~ postnatal day 12) and at time when the Kölliker’s organ is 
degenerated. This neural activity in early development mediated by ATP is considered to 





Figure B11. Mechanism underlies spontaneous activity in developing cochlea before 
hearing onset. (Wang et al., 2015) 
 
3.3 Purinergic signaling involved in acoustic damage 
Acoustic overexposure damages structures and cells in the middle and inner ear 
and can cause permanent hearing deficits. At very high sound pressure levels (e.g. blasts), 
the eardrum and the cochlea can be ruptured immediately, leading to permanent deafness 
(Hamernik et al., 1984; Kerr and Byrne, 1975). At lesser sound pressure levels (usually 
below 140 decibels), such as a loud concert, noise progressively damages sensory 
neurons in the inner ear, resulting in the death of outer hair cells (Figure B12), as well as 
swelling and retraction of type I afferent terminals which carry sound information to the 
brain (Kujawa and Liberman, 2009; Liberman and Kiang, 1978; Wong and Ryan, 2015). 
The effect of noise exposure can be long-lasting, with degeneration of SGNs over months 
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after noise exposure (Kujawa and Liberman, 2009). Unlike non-mammalian vertebrates, 
the sensory neurons in mammalian cochlea do not regenerate. The resulting loss of 
sensory components and the hearing deficits are thus irreversible. The acoustic stapedius 
reflex in the middle ear (Brask, 1979) and efferent inhibition of hair cells (Guinan, 2006) 
can attenuate acoustic damage to some extent. However, a more effective way is to warn 
the animal of the damaging level of sound and trigger avoidance behavior by means of 
nociception. 
 
Figure B12. Noise exposure damages OHCs. A. control. B. OHC swells after 24 hours 
exposure to noise band at 116 dB (arrow). C. Selective loss of outer hair cells after over 
one week exposure to 116 dB noise. (Wang et al., 2002) 
 
Interestingly, the concentration of ATP is increased in the cochlea during stress 
conditions in vitro and acoustic damage in vivo, serving as a potential nociceptive signal 
as in the somatosensory system. ATP is kept at low concentrations (10 - 20 nM) in the 
endolymph and perilymph (Munoz et al., 1995), likely due to the basal activity of various 
types of ectonucleotidases in the cochlea (Vlajkovic et al., 1996). After noise exposure 
(15 min, 10 kHz, 110 dB SPL. broad band), ATP concentration in the cochlear fluid is 
increased 2-3 fold, measured by the luciferase – luciferin assay (Munoz et al., 2001). 
ATP release also can be induced in physiological conditions, such as hypotonic stress 
(275 mOsm external solutions) and mechanical stimulation (puffing micro glass beads), 
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tested by a whole-mount in vitro preparation of adult guinea pig cochlea (Zhao et al., 
2005).   
 
Figure B13. Cochlear structures that are prone to damage and death over acoustic 
overstimulation. Shown in red. (Wong and Ryan, 2015) 
 
The source of ATP release includes multiple structures that are prone to acoustic 
damage, including the stria vascularis and the organ of Corti (Figure B13). Vesicular 
storage of ATP was found in the marginal cells of stria vascularis (Munoz et al., 2001; 
White et al., 1995), serving as a possible source of ATP after acoustic damage. ATP 
release from the organ of Corti is mediated by the connexin hemichannels in outer 
supporting cells, including Deiters’ and Hensen’s cells of the outer hair cell region. 
Mechanical or focal damage of a single outer hair cell is enough to trigger a Ca
2+
 rise in 
the surrounding supporting cells, causing ATP release through connexin hemichannels. 
ATP could further act on purinergic receptors of the adjacent cells, activating the inositol 
lipid signaling and mobilizing internal Ca
2+
 stores (Piazza et al., 2007). With such 
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positive feedback, this process triggers a regenerative Ca
2+
 wave that spreads hundreds of 
microns along the cochlear spiral, releasing a great amount of ATP over tens of seconds 
upon each outer hair cell ablation (Figure B14). This process is highly dependent on ATP 
release through the connexin hemichannels, because the propagation of Ca
2+
 waves can 
be blocked by apyrase that hydrolyzes ATP (Gale et al., 2004) and by connexin 
hemichannel blockers (Anselmi et al., 2008). Lanthanum, a blocker for cell surface-
expressed connexin hemichannels that does not affect gap junction between cells, was 
enough to limit the propagation of the calcium wave, suggesting that such process is 
dependent on extracellular release of ATP acting on the neighboring cells (Anselmi et al., 
2008). This mechanism is highly sensitive to ATP.  Application of nano-molar 
concentrations of ATP is enough to trigger the regenerative Ca
2+
 waves (Gale et al., 
2004). In addition, a faster ATP-dependent Ca
2+
 wave in outer hair cell rows has been 
observed to be triggered by hair cell damage and might be mediated by P2X4 receptors 
(Lahne and Gale, 2010). The oscillatory Ca
2+
 wave in the outer supporting cell region 
reflects a characteristic damage signal in the cochlea, which could further contribute to 
the activation of extracellularly regulated kinases 1 and 2 (ERK1/2) and c-Jun N-terminal 
kinase (JNK) (Gale et al., 2004; Lahne and Gale, 2008), leading to protective effects such 




Figure B14. A regenerative calcium wave triggered by ablation of a single hair cell. The 
calcium wave in control (A) can be blocked by apyrase, an enzyme that hydrolyzes ATP 
(B). (C) Calcium signal spreading from the site of damage can travel over a hundred 
microns. Grey: control; purple: in apyrase; gold: wash. (D) Comparison between 
measured wave speed (grey closed circle) and a diffusion model with varying coefficients 
(red) suggest an active mechanism for wave propagation. (Gale et al., 2004) 
 
Purinergic signaling has also been proposed as a protective mechanism against 
acoustic trauma by shunting K
+
 in the endolymph to reduce the endolymphatic potential. 
In the intact cochlea, the apical surface of outer hair cells is bathed in endolymph and the 
basolateral surface bathed in perilymph. In addition to this unique ionic composition, an 
endolymphatic potential (EP) of ~80 mV contributes significantly to the driving force and 
is essential for mechanotransduction in hair cells (Wangemann, 2006). The integrity of 
the endolymphatic compartment is ensured by the tight junctions of cells lining the scala 
media. It has been found that P2X2 receptors are expressed on the cell surfaces facing the 
endolymphatic compartment (Figure B15), including Reissner’s membrane, inner and 
outer sulcus cells and hair cells (Housley et al., 1999; Housley and Ryan, 1997; Jarlebark 
et al., 2000). It has been proposed that ATP released under stress conditions (e.g. acoustic 
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overstimulation) could activate P2X2 receptors. These non-selective cation channels 
surrounding the endolymphatic component allow ion flow and could shunt K
+
 out of 
endolymph, resulting in a measurable reduction of the EP. This mechanism is considered 
as neuroprotective because it reduces the responsiveness of hair cells through decreasing 
EP under stress conditions in the cochlea. This hypothesis was further tested in P2X2-null 
mice. Under noise exposure, lack of P2X2 receptors leads to enhanced activity of outer 
hair cells and in the inner hair cell – type I afferent pathway, measured by distortion 
product otoacoustic emission (DPOAE) and auditory brainstem response (ABR), and the 
P2X2-null mice were more vulnerable to noise-induced permanent hearing loss (Housley 
et al., 2013; Yan et al., 2013). A P2X2 mutation was shown to be associated with a 
dominantly inherited, progressive sensorineural hearing loss DFNA41 in human (Yan et 
al., 2013). Noise exposure might also dynamically regulate the expression of purinergic 
components in the cochlea, causing up-regulation of P2 receptors (Wang et al., 2003) and 
ectonucleotidases that hydrolyze ATP (Vlajkovic et al., 2004; Vlajkovic et al., 2006). 
 
Figure B15. P2X2 receptors are expressed in the cells lining the endolymphatic 
compartment in the mouse cochlea. P2X2 are expressed in the Reissner’s membrane 
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epithelial cells (RM), spiral limbus (sl), and organ of Corti (o/C), including IHCs and 
OHCs. sm, scala media; stv, stria vascularis; sv, scala vestibuli. (Housley et al., 2013) 
 
4. Hypersensitivity in pain and auditory pathologies 
4.1 Purinergic signaling and pain 
The hypothesis that ATP serves a nociceptive signal in the ear invites comparison 
with the canonical pain mechanism in the somatosensory system. ATP has been 
identified as an algogenic reagent through early studies demonstrating that injection of 
ATP into human skin blisters induces the sensation of pain (Bleehen and Keele, 1977; 
Collier et al., 1966). Animal models with sub- or intra-plantar injection of ATP could 
also induce nocifensive behavior, such as hindpaw lifting and licking (Bland-Ward and 
Humphrey, 1997; Hamilton et al., 1999). Homomeric P2X3 receptors and heteromeric 
P2X2/3 receptors were localized predominantly to the non-peptidergic small nociceptive 
sensory neurons in dorsal root ganglion (DRG). At L4/5 P2X3 positive neurons were 
found to constitute ~35% of the DRG neurons (Bradbury et al., 1998; Chen et al., 1995; 
Lewis et al., 1995). These pseudomonopolar neurons give off unmyelinated C-fibers, 
with central projections terminating at the inner lamina II of the dorsal horn and 
peripheral terminals targeting skin, oral cavity and visceral organs (Burnstock, 2009; 
Burnstock, 2013).  P2X receptor-expressing small diameter DRG neurons were found to 
largely overlap with the subpopulation that is labeled by the isolectin IB4 (Bradbury et al., 
1998). ATP responses have been extensively characterized using whole cell gigaohm 
recordings of dissociated DRG neurons. Most of the DRG neurons respond to ATP with a 
transient current, whereas other subpopulations of DRG neurons developed persistent or 
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biphasic responses to ATP. This discrepancy has been attributed to the different subtypes 
of P2X receptors expressed – P2X3 receptors mediated the fast desensitizing transient 
responses; P2X2 receptors mediating the slowly desensitizing responses; coexpression of 
P2X2/3 receptors demonstrating both features and the responses becoming biphasic 
(Burgard et al., 1999; Rae et al., 1998). This has been further confirmed in knockout mice 
that P2X3
-/-
 DRG has more sustained responses and P2X2
-/-
 has more transient responses 
(Cockayne et al., 2005; Zhong et al., 2001). Double mutants for both receptors eliminate 
DRG neurons’ responses to ATP and the animal had reduced pain-related behavior 
(Cockayne et al., 2005). As previously discussed, ATP can be released from many kinds 
of non-neuronal tissues during hypoxia or tissue stress, as well as from dying or damaged 
cells. In an in vitro preparation, it has been shown that nociceptive neurons could be 
activated when a nearby skin cell was damaged. The response was ATP and P2X receptor 
dependent and could trigger action potentials in these nociceptors (Cook and McCleskey, 
2002). ATP is thought to be involved in acute pain. It has also been shown that during 
inflammation or in the presence of other algogenic compounds, ATP may contribute to 
increased sensitivity to mildly painful stimuli (hyperalgesia) or to painful sensations to 
previously innocuous stimuli (allodynia). In carrageenan – inflamed skin, there was an 
increased number of ATP responsive neurons in the DRG, and the C-fibers’ responses 
were enhanced (Hamilton et al., 2001). Locally injected ATP could sensitize the 
mechanosensitive fibers, leading to elevated nociceptive responses to pressure or touch 
(Zhang et al., 2001). 
The role of P2Y receptors in pain was less studied compared to P2X receptors. In 
DRG neurons, mRNA of various P2Y receptors has been detected, including P2Y1, 
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P2Y2, P2Y4 and P2Y6 (Kobayashi et al., 2006). Among them, P2Y2 receptors have been 
proposed as the major form of DRG expressing P2Y receptor (Malin et al., 2008), and 
P2Y receptors have been found to localize with P2X3 receptors as well as the capsaicin-
sensitive transient receptor potential vanilloid 1(TRPV1) channels (Gerevich and Illes, 
2004; Ruan and Burnstock, 2003). Signaling through P2Y receptors in DRG neurons has 
been shown to cause release of Ca
2+
 from intracellular stores (Sanada et al., 2002), affect 
thermal nociception (Malin et al., 2008), and seems to potentiate pain induced 
mechanically or chemically via TRPV1 channels (Moriyama et al., 2003).  
 
4.2 KCNQ channels and neuronal excitability regulation 
As mentioned above, chronic pain could involve a decreased threshold to painful 
stimuli - hyperalgesia. Allodynia refers to the pain that occurs in response to normally 
innocuous stimuli. Chronic pain is usually associated with enhanced or abnormal 
excitability of neurons, for example the nociceptors or central neurons demonstrating 
enhanced responsiveness or lowered threshold for stimulation and synaptic inputs 
(Sandkuhler, 2009). Potassium channels play an important role in regulating neuronal 
excitability. All of the four major groups of potassium channels (i.e. voltage-gated, two-
pore, calcium-activated and inward rectifying potassium channels) have been examined 
in DRG neurons in pathologies related to pain. Opening of potassium channels was 
proposed to reduce excitability of the sensory neurons. This mechanism could counteract 
action potential generation at the peripheral terminals, decrease overall conduction 
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fidelity along the fibers and affect synaptic transmission onto the central neurons 
(Tsantoulas and McMahon, 2014).  
Among the potassium channels, some are known to be regulated by G-protein 
coupled second messenger pathways, so could be modulated by nucleotides (e.g. ATP).  
P2Y receptor regulated potassium channels include GIRK (G protein-coupled inward 
rectifiers K
+ 
channels) and KCNQ (potassium voltage-gated channel subfamily Q) 
channels. GIRK channels can be activated by Gi/o-coupled metabotropic receptors. 
Activation of Gq/11 pathway may also modulate GIRK channels, leading to decreased 
activity through activation of protein kinase C or depletion of PIP2 (phosphatidylinositol 
4,5-bisphosphate) (Luscher and Slesinger, 2010). A role for GIRK channels in 
hyperalgesia has been suggested in both peripheral and central neurons. Phosphorylation 
of GIRKs decreases channels activity and is thought to promote sensitization at dorsal 
horn of the spinal cord following neuropathy or inflammation (Ippolito et al., 2005). 
GIRKs are also found to be associated with the analgesic effect of opioids and 
endocannabinoids (Nockemann et al., 2013; Ocana et al., 2004). 
On the other hand, current findings suggest that KCNQ channel modulation by G 
protein-coupled pathways is solely by inhibition. KCNQ channels belong to the Kv7 
family voltage-gated potassium channels. They are also called ‘M-channels’ due to the 
first identification of these channels through muscarinic suppression (Brown and Adams, 
1980). The ‘M-currents’ recorded in bullfrog sympathetic neurons were found to be 
inhibited by the application of ATP and UTP in the early days (Adams et al., 1982; 
Akasu et al., 1983). Later studies suggest that the mechanism of KCNQ channel 
40 
 
inhibition is due to the reduction of PIP2 as a result of Gq/11 activation. It has been shown 
that PIP2 is crucial for keeping the KCNQ channels open (Robbins et al., 2006; Suh and 
Hille, 2002; Suh et al., 2006; Zhang et al., 2003) by binding to the C-terminus of the 
channels (Hernandez et al., 2008). Activation of metabotropic receptors that link to Gq/11 
(for example muscarinic acetylcholine receptors, P2Y receptors, histamine H1, mGluR1 
and mGluR5 glutamate receptors) leads to activation of phospholipase C that rapidly 
hydrolyzes PIP2, causing a great reduction (up to 90%) of membrane PIP2 within a few 
seconds (Suh et al., 2004; Winks et al., 2005). As a consequence, KCNQ channels are 
closed upon receptor activation (Brown and Passmore, 2009). 
 
Figure B16. Physiological properties of KCNQ channels. A. KCNQ channels are slow 
activating and do not inactivate. Right: the increase in whole-cell conductance as a 
function of voltage changes. B. KCNQ currents ‘clamps’ the membrane potential. 




The voltage-gated KCNQ channels have some unique properties. They are 
activated slowly by depolarization (usually tens of milliseconds) and therefore do not 
contribute to individual action potentials (for example the repolarization phase) which 
occurs on a much faster time scale. KCNQ channels start to activate around the normal 
resting membrane potential (~ -60mV) but do not inactivate, generating a steady outward 
current at depolarizing voltages (Figure B16 A). Therefore KCNQ channels are important 
for neuronal excitability and could serve as a ‘brake’ on repetitive firing (Figure B16 B) 
(Brown and Passmore, 2009; Delmas and Brown, 2005). At more depolarized voltages 
when many KCNQ channels are opened, the effect of further depolarization could be 
counteracted by the shunting effect of opened KCNQ channels. For example the same 
current injection step at -46 mV (~30% opened KCNQ channels) induced a much smaller 
depolarization than at -90 mV (all closed). In this way KCNQ channels have a profound 
dampening effect on repetitive firing and when cells are depolarized (Brown, 1988). 
Consequently, activation of GPCRs or pharmacological manipulations that close these 
channels would lead to elevated neuronal excitability and in some cases an altered tonic 
firing pattern. In rat sympathetic neurons, retigabine (a KCNQ channel opener) enhanced 
the M current that hyperpolarized the neuron and stopped firing. XE991 (a KCNQ 
channel blocker) reduced the M current and made the neuron more excitable, changing 
from a phasic to tonic firing pattern (Figure B17) (Brown and Passmore, 2009). Among 
DRG neurons, KCNQ channels were found co-expressed with TRPV1 channels in small 
neurons (Passmore et al., 2003). Opening of KCNQ channels by retigabine was found to 
decrease the activity of Aδ and C fibers, and could exert analgesic effects on 
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somatosensory pain (Blackburn-Munro and Jensen, 2003; Dost et al., 2004; Lang et al., 
2008; Passmore et al., 2003; Rivera-Arconada and Lopez-Garcia, 2006) 
 
Figure B17. Enhancing or blocking KCNQ channels affect excitability of dissociated rat 
sympathetic neurons. Retigabine: KCNQ opener. XE991: KCNQ blocker. (Brown and 
Passmore, 2009) 
 
KCNQ channel dysfunction has been linked to human diseases. Among the five 
subtypes, KCNQ4 mutation leads to DFNA2 (autosomal dominant deafness locus 2), a 
nonsyndromic, dominant progressive hearing loss (Kharkovets et al., 2000; Kubisch et al., 
1999). KCNQ4 channels are expressed in OHCs and IHCs (Kubisch et al., 1999; 
Mammano and Ashmore, 1996; Marcotti and Kros, 1999), and were found to be 
important for IHC resting membrane potential and intracellular calcium levels (Oliver et 
al., 2003). Immunolabeling for KCNQ2 and KCNQ3 showed expression in spiral 
ganglion neurons (Jin et al., 2009). Expression of KCNQ4 was also detected in spiral 
ganglion neurons, and like their expression in the IHCs, there was a basal-to-apical 
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gradient such that expression was highest at the base of the cochlea (Beisel et al., 2000). 
Recordings from isolated SGNs revealed a corresponding gradient. A larger KCNQ 
channel current was recorded in basal SGNs.  Inhibition of these channels is thought to 
promote cell death through elevated intracellular calcium concentration (Lv et al., 2010).  
These studies on SGNs mostly represent the major population – type I neurons.  No 
report has determined if type II neurons express KCNQ channels or demonstrate KCNQ 
channel mediated currents. 
 
4.3 Hypersensitivity in tinnitus and hyperacusis 
Tinnitus – the phantom perception of sound, refers to conditions involve ringing 
or buzzing sensation in the ear in the absence of acoustic stimuli. It often co-occurs with 
hyperacusis, a hypersensitivity to moderate acoustic levels, which in severe cases can be 
debilitating due to the reduced tolerance and even painful perception in response to 
normal levels of sound (Andersson et al., 2002; Auerbach et al., 2014). Tinnitus is highly 
prevalent. One third of people have experienced tinnitus and 10 – 15% of general 
population had prolonged symptoms for which they seek medical attention (Heller, 2003). 
Although hyperacusis is less reported than tinnitus, it has been estimated that hyperacusis 
occurs in ~80% of tinnitus patents (Dauman and Bouscau-Faure, 2005). Despite the large 
population being affected, understanding of the pathophysiology of tinnitus and 
hyperacusis is very limited, and currently there is no effective treatment for these diseases. 
The induction of the two ‘hypersensitive’ conditions has been highly correlated 
with noise exposure. Damage to the cochlea is a known high risk factor for tinnitus and 
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hyperacusis, and patients often report a prior history of noise trauma (Anari et al., 1999; 
Auerbach et al., 2014; Ince et al., 1987; Kreuzer et al., 2012). However, noise damages 
the auditory periphery, reduces the cochlear output from the auditory nerves (mostly type 
I afferents) and leads to elevated hearing thresholds (Wang et al., 2002). After noise 
exposure, fusion of the stereocilia of hair cells or the damage to OHCs affects sound 
transduction as well as tuning and amplification of the signal, so that higher stimulation 
intensity is needed to drive the responses (Liberman, 1978; Liberman and Kiang, 1978). 
Some patients who have ‘normal’ clinical audiograms may also develop tinnitus and 
hyperacusis (Brandy and Lynn, 1995). Such phenomenon might be related to the 
damaged IHC-type I afferent synapses and loss of type I SGNs due to relatively mild 
noise stress (Kujawa and Liberman, 2009), and this noise-induced cochlear neuropathy 
has been linked to hyperacusis in animal models (Hickox and Liberman, 2014).  
The decreased activity of cochlear outputs after noise makes it hard to explain the 
hypersensitivity to sound in tinnitus and hyperacusis. So, instead of peripheral 
sensitization, several studies proposed a ‘central gain enhancement’ mechanism using 
animal models and human subjects.  At multiple levels of the central auditory pathway, 
including the cochlear nucleus, inferior colliculus and the auditory cortex, enhanced 
spontaneous and sound-evoked responses were recorded after the induction of tinnitus, 
which is in sharp contrast to the reduced activity of auditory nerves (Auerbach et al., 
2014; Eggermont, 2013). However, the activity of the two classes of auditory nerves – 
type I and type II afferents has never been examined separately and it is unknown how 
type II afferents respond to the noise paradigm that induces pathological conditions. 
What has been known for long time is that type II afferents are resistant to noise or 
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ototoxic damage to the cochlea. Unlike type I afferents that could retract from the site of 
damage, type II afferents remain in the cochlea even after the loss of OHCs (Ryan et al., 
1980; Spoendlin, 1971b). Whether type II afferents could be involved in pathological 
conditions would be an interesting question to pursue. 
 
5. Main objectives of this thesis 
As summarized above, the function of the unmyelinated type II afferents in the 
cochlea remained enigmatic for decades. Here, we provide evidence that type II cochlear 
afferents can report cochlear trauma, a potential trigger for nocifensive behavior. 
Hyperactivity of type II neurons could contribute as well to the paradoxical 
hypersensitivity to loud sound that can accompany hearing loss – hyperacusis, despite 
diminished type I afferent function. In the most severe cases, hyperacusis is described as 
debilitating “ear pain”. The response to trauma by type II afferents may relate most 
directly to such noxious hearing—“noxacusis,” to coin a term. In support of this 
hypothesis, sparse (~5% of all spiral ganglion neurons) unmyelinated type II afferents 
can survive cochlear damage, are insensitive to sound, but are activated by the algogenic 
ligand adenosine triphosphate (ATP). In contrast to the predominant type I afferents that 
contact IHCs to encode the information content of sound, type II afferents innervate 
OHCs, which are more sensitive to acoustic trauma. Here, we show that type II afferents 
are excited by ATP released from supporting cells around damaged OHCs, revealing 
cellular mechanisms and potential molecular pathways for inner ear pain. 
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In Chapter 1, we describe the general morphology, as well as the features of the 
synaptic region of type II afferents revealed by biocytin fills of these fibers during 
electrophysiological recordings. 
In Chapter 2, we examine the possible postsynaptic receptors at type II afferents. 
Using more specific pharmacological reagents as well as immunohistochemistry 
experiments, we were able to identify the GluA2-containing AMPA-type glutamate 
receptors on type II afferents, which had been controversial previously due to the 
nonspecific pharmacology used and failure in staining for any glutamate receptors in the 
OHC region. 
In Chapter 3, we showed that in contrast to the weak synaptic inputs, ATP 
potently activated type II afferents. The responses were mediated by two classes of 
purinergic receptors, ionotropic P2X receptors and metabotropic P2Y receptors. The P2X 
receptors are nonselective cation channels that depolarize type II afferents in the presence 
of their agonist ATP. The P2Y receptors are G-protein coupled receptors and signal 
through second messenger-mediated pathways. We found that KCNQ channels are closed 
in response to P2Y receptor activation. 
In Chapter 4, we demonstrated that type II afferents responded robustly to OHC 
damage. The mechanism involves ATP released from supporting cells triggered by 
damage, serving as the major source of ATP activating type II afferents in this process. 
Activation of the P2Y-KCNQ pathway might also lead to increase excitability of type II 
afferents, which may suggest heightened responses of type II afferents when acoustic 
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Electrophysiological recordings from type II cochlear afferents 
The cochlea was dissected from Sprague Dawley rat pups (Postnatal day P7-P10) 
according to a protocol approved by the Johns Hopkins Institutional Animal Care and 
Use Committee. Each animal was put into deep anesthesia by inhalation of isoflurane 
(Vedco, Inc.), ensured by a foot pinch test. Then the animal was decapitated and the 
temporal bone was removed. The apical turn of the cochlea was dissected for ex vivo 
recording according to published procedures (Glowatzki and Fuchs, 2002). After 
removing bone and surrounding tissues, the apical turn of the cochlea was exposed and 
severed at the modiolus. The stria vascularis and tectorial membrane were removed. The 
dissected cochlear turn was flattened and secured with an inset pin glued to a coverslip 
for electrophysiological recordings. 
Electrophysiological recordings were done under a microscope (Carl Zeiss 
Examiner D1) using differential interference contrast (DIC) optics.  A cleaning pipette 
was made by breaking a regular patch pipette at the bottom of the recording chamber. 
The size of the tip was determined by the pressure against the chamber controlled by a 
micro-manipulator (Sutter Instruments) along z-axis and breaking of the pipette was 
visualized with a monitor. 4-to-6 OHCs in row 2 and 3 were removed by the cleaning 
pipette to expose the dendrites of type II cochlear afferents (Weisz et al., 2009). Very 
often the Deiters’ cells below the removed OHCs died within a few minutes due to the 
damage to their phalangeal processes that insert between OHC rows. The debris of these 
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supporting cells was also removed using the same cleaning pipette by gentle inhalation or 
exhalation. After removal of OHCs and Deiters’ cells, two layers of type II afferents 
could be identified, traveling parallel to the cochlear spiral. The first layer sits right under 
OHCs, and a second layer is situated deeper at the Deiters’ cell level and organized in 
wider bundles. Most of the recordings (tight-seal intracellular recordings or loose-patch 
extracellular recordings) were performed at the first layer around the terminal region of 
the fiber, where type II afferents rise to the base of outer hair cells and form synapses. 
Recording pipettes (resistances of 6-9 MΩ) were pulled from 1mm borosilicate glass 
(WPI Instruments). The series resistances of the recordings were less than 35MΩ 
(membrane test of the pCLAMP 10.3 software - Molecular Devices) and were not 
corrected. In loose patch recordings, the final seal resistance reaches around 3-4 times the 
pipette resistance.  
Solutions 
Extracellular solution contained (in mM): 5.8 KCl, 144 NaCl, 1.3 CaCl2, 
0.9 MgCl2, 0.7 NaH2PO4, 5 glucose, 10 HEPES, pH 7.4. The excised cochlear tissue was 
constantly perfused with the extracellular solution under a rate of two seconds/drop. 
Intracellular solution contained (in mM): 135 KCl, 0.1 CaCl2, 3.5 MgCl2, 5 K-EGTA, 
5 HEPES, 5 NaCl, pH 7.2 (4 mV junction potential, not corrected). During the voltage 
ramp protocol, 1µM tetrodotoxin was added to the bath to prevent action currents. In 
some experiments, a high potassium solution was used to depolarize neurons and trigger 
synaptic transmission, which contains 40 KCl, 110 NaCl, 1.3 CaCl2, 0.9 MgCl2, 
0.7 NaH2PO4, 5 glucose, 10 HEPES, pH 7.4. For cell ablation studies, in order to 
50 
 
improve stability,  recordings were made with intracellular solution containing organic 
anions in place of Cl (in mM): 110 K-methanesulfonate, 20 KCl, 0.1 CaCl2, 3.5 MgCl2, 
5 K-EGTA, 5 HEPES, 5 Na2phosphocreatine, 0.3 Tris-GTP, pH 7.2.  Membrane 
potentials were corrected for the 10 mV junction potential with this solution.  ATP was 
excluded from all intracellular solutions to prevent desensitization of ATP receptors. 
Pharmacological compounds 
Pharmacological compounds were applied with a gravity-driven, large bore 
application pipette placed to cover the spiral branch of the recorded afferent. In some 
experiments, drugs were loaded in a puffer pipette (with the same tip size as the patch 
pipette) and applied locally driven by a Picospritzer III (Parker-Hannifin, Irwin PA). All 
chemical and pharmacological reagents were obtained from Sigma, except for PPADS 
(Tocris), tetrodotoxin (Tocris), CNQX (Tocris), D-AP5 (Tocris), (RS)-MCPG (Tocris), 
retigabine (Sigma and Alomone labs), and FM 1-43FX (Life Technologies).  
Cell ablation strategy 
Cell ablation was performed mechanically, using a sharp needle pulled from 1mm 
borosilicate glass. The needle was placed parallel to the cochlear spiral, and was moved 
manually using a micro-manipulator. This ablation procedure started 15-20 outer hair 
cells apical to the recording site, to encompass the synaptic zone of the fiber. To visualize 
hair cell ablation, the cochlear tissue was preloaded (25-30 seconds, room temperature) 
with 5 µM FM1-43, a fluorescent dye that rapidly enters through mechanotransduction 
channels and partitions into the hair cell membrane. In each trial, one to three OHCs were 
ruptured by the movement of the needle through the lateral wall of the cell.  Rupture was 
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effected only when the needle was centered on the cell nucleus.  After ablation, the 
damaged outer hair cell swelled immediately and disappeared entirely within 3 – 5 
minutes, confirmed by the loss of FM1-43 from the hair cell membrane. There was 
minimal damage to the surrounding cochlear cells including the afferent neurites, Deiters’ 
cells and Hensen’s cells.  
Post hoc visualization of biocytin-filled type II afferents 
For post hoc visualization of the afferent, 0.25~0.3% biocytin was added to the 
intracellular solution. The tracer was detected using streptavidin-conjugated horseradish 
peroxidase, made visible by precipitation of diaminobenzidine (DAB) for light 
microscopy. After whole-cell patch clamp recording, tissue with biocytin-filled type II 
afferents was fixed in 4% PFA overnight at 4°C in a 12-well cell culture plate (Corning), 
and then washed in PBS and stored at 4°C for further batch processing within two weeks. 
In a new 12-well plate, each tissue was washed in PBS on a shaker (washed twice for 10 
min each, and the third time for 30 min) and then quenched in 10% H2O2 (with 10% 
methanol) for 10 minutes. Time has to be controlled precisely (count in seconds) for the 
critical quenching step. After that the tissue was washed three times in PBS for 10 min 
each, and permeabilized in 2% Triton in PBS (1 hour, room temperature). Then the tissue 
was incubated in avidin/biotin complex (Vectastain ABC kit, Vector) overnight at 4°C, 
washed in PBS (twice for 10 min each time and then 45-60 min for the third time) and 
reacted with a diaminobenzidine-based peroxide substrate (ImmPACT DAB, Vector) for 
10 minutes, until the cell and its arborization were visible under the microscope. The first 
rinse using PBS was done immediately to stop the reaction, followed by two additional 
52 
 
rounds of wash by PBS for 10 min each. Then the tissue was mounted on a microscope 
slide for imaging.  
Equipment and settings for digital images 
After the DAB reaction, the slides for cochlear turns were imaged on a Zeiss LSM 
510 Meta microscope. For cell ablation studies, the cochlea was viewed under 
a microscope (Carl Zeiss Examiner D1) using a 40× water-immersion objective with 
contrast enhancement (Hamamatsu C2400-62). Images were taken with a digital camera 
(SONY) attached to the microscope. 
Preparation for calcium imaging 
To examine the calcium responses of SGN afferents, Advillin-Cre mice were bred 
into a R26-lsl-GCaMP3 (GCaMP3) mouse line (Paukert et al., 2014) which expresses the 
genetically encoded calcium sensor GCaMP3 in the Cre recombinase positive cells. The 
Advillin-Cre mouse line was generated by knocking the transgene Cre into the Advillin 
gene locus (da Silva et al., 2011). This construct was found to sparsely label both type I 
and type II afferents, with increasing numbers of labeled neurons from apex to base 
(Zhang-Hooks et al., 2016). Although it has been suggested that only male Advillin-Cre 
mice could be used to achieve specific labeling of sensory neurons (da Silva et al., 2011), 
by the time for experiments only female Advillin-Cre mice were available for us to cross 
with the male GCaMP3 mice. Two thirds of the pups in the resulting litter demonstrate 
nonspecific expression of the Cre recombinase that drives expression in neurons and 
supporting cells. The rest of the pups have specific expression of the Cre recombinase in 
the sensory neurons. We found such difference in expression pattern could be easily 
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identified by looking at the basal fluorescence of GCaMP3 in the animals’ tail, where 
nonspecific vs. specific expression could be distinguished.  
The transgenic mice were dissected at postnatal day P5 – P7 and the cochlear 
explant was obtained as described previously. Segments of cochlea including apical and 
middle turns were put into culture. They were attached onto cover slips after coating with 
Cell-Tak (Corning) and incubated in a medium containing Dulbecco's modified Eagle's 
medium (DMEM), 1 % fetal bovine serum (FBS) and 0.1 % penicillin. After one day in 
culture, the cochlea with the cover slip was transferred under a laser scanning confocal 
microscope LSM 710 (Zeiss) for calcium imaging and was superfused with extracellular 
solution during the experiments. The microscope was equipped with a 20X water-
immersion objective, 488 nm laser illumination, and 500–530 nm bandpass filter. DIC 
images were simultaneously monitored to visualize the sharp needle for ablation studies. 
Images were collected for one frame/second.  
Data acquisition and analysis 
Membrane voltage and current were recorded with a MultiClamp 700B amplifier 
and a Digidata 1440A (Molecular Devices), controlled by pCLAMP 10.3 software 
(Molecular Devices), sampled at 25 kHz and low-pass filtered at 10 kHz. The data were 
analyzed in pCLAMP 10.3 (Molecular Devices) and Origin 9.0 (Origin Labs). Statistical 
analysis (paired or unpaired t-test as appropriate) was performed in Excel (Microsoft) and 
the results are given as mean ± SD. EPSCs were analyzed using MiniAnalysis software 
(Synaptosoft) with the criterion three times the root mean square of the noise, and further 
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accepted or rejected by eye according to their characteristic waveforms. Calcium imaging 



















Chapter 1: Morphology of type II cochlear afferents 
The morphology of type II neurons, including their somata, peripheral innervation 
onto multiple OHCs and branching patterns as outer spiral fibers have been characterized 
by many studies (Berglund and Ryugo, 1987; Brown, 1987a; Echteler, 1992; Ginzberg 
and Morest, 1983; Ginzberg and Morest, 1984; Huang et al., 2007b; Koundakjian et al., 
2007; Liberman et al., 1990; Perkins and Morest, 1975; Simmons and Liberman, 1988a; 
Simmons and Liberman, 1988b). Among them, informative morphological understanding 
was gained through the sparse labeling that shows single fibers of type II afferents, using 
either Golgi staining (e.g. Perkins and Morest, 1975) or HRP fills into the central-going 
axons of SGNs near the cochlea nucleus.  With the latter method the marker has to travel 
long distance in order to reach the cochlea and label their peripheral processes in the 
organ or Corti (e.g. Simmons and Liberman, 1988a). In this thesis, we employed a 
different strategy. We included biocytin directly into the patch pipette. When whole-cell 
patch clamp recordings were established on type II afferents’ dendrite terminals, the 
biocytin entered through the closest site to the synaptic region and might be ideal for a 
more complete fill to visualize the finest structures. Combined with streptavidin-
conjugated fluorescent labeling, this method could further allow association of type II 
afferents labeling with immunolabeling for synaptic marker proteins (in Chapter 2), 




1.1 General properties of peripheral innervation 
To label the peripheral type II fibers and to understand their specific connectivity 
with OHCs, giga-ohm-seal intracellular recording was used to fill  type II fibers with 
biocytin in excised apical turns of cochleae from young rats (postnatal days P7 to P9).  
Before each experiment, biocytin solution was made by mixing 0.0025 – 0.0030 g 
biocytin into 1 mL intracellular solution. The mixture was made in a 1.5 mL tube and was 
sonicated for at least 5 minutes, until biocytin was fully dissolved and clear solution was 
obtained. The biocytin-containing intracellular solution was then filled into the patch 
pipettes through a capillary attached to a syringe and a micro-filter.  
Once giga-ohm seal was established between the patch pipette and the type II 
afferents’ dendrite, a brief suction was applied to rupture the cell membrane and allow 
diffusion of biocytin into the cytosol of the recorded afferents. The identity of the 
recorded type II afferents was further confirmed by their characteristic voltage-gated 
currents elicited by voltage steps (Figure 1.1.1) (Weisz et al., 2009). Remarkably, we 
found that the dialysis process was fast and biocytin could travel a long distance within 
the cell. Only five to ten minutes of whole-cell patch clamp recording on a type II 
afferent was enough to label the entire neuron, including its distal dendrites (the 
recording site) and synaptic branches, its spiral process under OHCs and supporting cells, 
its radial process and turning point, their somata in the spiral ganglion and even part of 
their central-going axons. Because of the difficulty of the recordings on these thin 
dendrites, multiple trials were made trying to patch onto the type II afferents before a 
good whole-cell patch clamp recording was achieved. For the unsuccessful trials, 
sometimes the cell membrane was only partially ruptured that allows in small amount of 
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biocytin. Therefore, although from trial to trial recordings were made from the same site 
on the outer spiral bundle (composed of many type II afferents bundled together) in a 
cochlear tissue, in a few cases multiple type II afferents were labeled in the same tissue, 
which can be visualized after streptavidin-peroxidase processing. This may cause 
difficulty in resolving single fibers for quantitative analysis of their morphology. In other 
cases, the soma of the recorded fiber was severed during the initial dissection of the 
apical turn, so that the biocytin labeling yielded type II fibers filled until the cut edge of 
their radial branch without showing their soma.  
 
Figure 1.1.1. Currents evoked by voltage steps in type II afferents (10mV steps from -
90mV). Cell# A_CL_010913 
 
 
Among the 40 whole-mounts with filled type II afferents, we selected 15 of them 
using the criteria including (1) single fiber are clearly labeled in each tissue; (2) a good 
signal-to-noise ratio and high quality of the image, allowing identification of the fine 
synaptic branches under OHCs; (3) helicotrema (the very apex of the cochlea) is seen in 
the tissue in order to decide the tonotopic location of the labeled fiber. These 15 slides 
were used for quantitative morphological characterization. Important parameters of the 
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fiber including the length of their processes, their location along the cochlea’s tonopic 
map, and characters of their synaptic regions were measured and counted with the 
software ImageJ. The length measurement in ImageJ was made by drawing the lines 
faithfully following the shape of the fiber using a computer mouse. Some of the 
remaining slides that provide interesting information were also described in the later part 
of this chapter. Most of my recordings were made on type II afferents under row 3 OHCs 
in the apical turn of young rat (P7-P10), so this study only reflects the morphology of 
type II afferents under these specific conditions. 
 
1. ‘Single arbor’ fibers 
Among the 15 quantified type II neurons, 8 of them gave off a single peripheral 
process without any major branching. The peripheral neurite leaves the soma in the spiral 
ganglion to cross the floor of the tunnel of Corti and turns ~ 90 degrees to travel toward 
the cochlear base (representing higher frequency regions) along the outer spiral bundle  
(Figure 1.1.2 A). Close to its turning point, the fiber often switches between OHC rows.  
After traveling several hundred microns, the spiral process seems to innervate mostly one 
row of OHCs, rising from under the Deiters’ cells to the base of the OHCs. The single 
spiral process averaged 714 ± 229 (SD) µm (n=8 fibers, see Table 1.1.1) from the turning 
point to the basal-most tip. At the terminal region where the type II afferent rises to travel 
right under OHCs, an average of 17 ± 4 (SD) short branches off the spiral process formed 
en passant and terminal swellings (Figure 1.1.2. B), presumably the site of synaptic 
transmission. The somata of type II neurons can also be visualized with great detail 
(Figure 1.1.2. C), sending the radial process toward the organ of Corti and a central 
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process projecting to the cochlear nucleus. The recording site of the biocytin-containing 
patch pipette often can be identified by a darker surrounding region, likely caused by the 
leakage of biocytin before giga-ohm-seal was established (Figure 1.1.2.A arrowhead). 
This location was seen close to the distal (basal) end of the fiber usually within one third 
of the length of the entire spiral process. Figure 1.1.3 and Figure 1.1.4 shows two other 
examples of labeled type II afferents with varying length and synaptic features. The 
shorter afferents in Figure 1.1.3 have only one major synaptic input region and the 
morphological synaptic branches were more clustered. The longer afferents in Figure 
1.1.4 had a spiral process that averaged 1194.7 µm and a more dispersed synaptic input 
region. Among the 21 synaptic branches observed, 11 of them clustered to form a major 
synaptic input region and 3 clustered to form a secondary synaptic region. There were 





Figure 1.1.2. A. Whole-mount view of a biocytin-filled type II spiral ganglion neuron in 
the apical turn of P8 rat cochlea. Recording site (arrowhead) was located on the 
terminal of the spiral branch, where type II afferent forms synaptic contacts with multiple 
outer hair cells. B. Confocal image of the type II afferent in A near recording site. 
Branches extend from the shaft onto the row of OHCs above it. C. The biocytin-filled 














Slide number  









Major synaptic area  synaptic area2 











BCL 9-24-12 899.2 843 1 21 1532 97.3 13 1456.198 30.754 4 
A CL 040114 516.4 1121 1 13 1448.3 150.2 9 1416.496 48.409 4 
ACL 032714 1194.7 566.5 1 21 1618.3 165.2 11 1237.851 38.181 3 
ACL 012214 617.8 613.5 1 12 1082.2 160.5 12     - 
3-17-13 Cell B CL 585.5 997.8 1 15 1109 52.8 9     - 
9-9-13 Cell A 733.9 658.1 1 22 1108.3 161.3 12 1336.511 104.051 8 
ACL 03-28-14 549.1 608 1 17 920.3 224.8 17     - 
A CL 10-03-12 612.8 NA 1 13 NA 101.3 12     - 
Average ± STD 714±229     17±4   139±53 12±3       
 
Table 1.1.1. Morphological Analysis of eight single arbor type II afferents. 
 
 
Figure 1.1.3. A single arbor type II afferent in the apical turn of young rat cochlea. Cell# 
A-CL 012214. Spiral process length was 617.8 µm. This afferent has one single synaptic 




Figure 1.1.4. A single arbor type II afferent in the apical turn of young rat cochlea. Cell 
# A CL 032714. Total length of the spiral process is 1194.7 µm. The major synaptic area 
has 11 synaptic branches and a secondary synaptic region has 3 branches. 
 
2. Multiple arbor fibers 
The spiral dendrite also could split into 2 (6/15 fibers) or 3 (1 fiber) major 
basally-projecting arbors.  More often, 5 out of 7 multiple arbor fibers showed major 
branched arbors on their basalward going spiral processes in the OHC region (e.g. Figure 
1.1.5). The two exceptions include one fiber with a branched arbor on its radial process 
(Figure 1.1.6), and one fiber with bifurcated arbors extending both basally and apically. 
In the second case, synaptic branches were only detected in the basal going arbor but not 
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the apical going arbor. The apical going arbor also showed a ‘ball-like’ structure at its 
terminal that seems to suggest some developmental defect during the neurite growth 
(Figure 1.1.7).  
Despite some morphological diversity, the overall length of the spiral process, the 
number of synaptic branches and terminal arborization zones were similar among single 
vs multiple arbor fibers. Multiple arbor fibers had a spiral process averaging 619 ± 208 
µm in length (Table 1.1.2, n=7 fibers), not significantly different from that of single arbor 
fibers (averaged 714 ± 229 µm, Table 1.1.1, n=8 fibers). Although the multiple arbor type 
II afferents have one or two more major processes, in 5 of 7 such cases, terminal branches 
arose from only one of the arbors, or prior to the branch point (Figure 1.1.5.Two 
exceptions in Figure 1.1.8). Morphological analysis revealed an average of 16±7 synaptic 
branches and a major synaptic region stretching 140±41 µm in multiple arbor type II 
afferents (Table 1.1.2), similar to these parameters quantified for single arbor type II 
afferents (Table 1.1.1). Therefore, all the analyzed fibers, whether possessing one or 
more major arbors, had similar numbers and distribution of terminal branches, and 




Figure 1.1.5. A multiple arbor type II afferent in the apical turn of young rat cochlea. 
Fiber branches and the distal terminal. Synaptic branches were found on the dendrite 










Figure 1.1.7. A cochlear tissue with two labeled fibers – one single arbor type II afferent 
and one multiple arbor type II afferent projecting bi-directionally. Cell# A CL 9-17-12. 
 
 
Figure 1.1.8.The only 2 out of 15 labeled fibers showing synaptic branches on multiple 
arbors.Cell# A_CL_092412 and B_CL082913. 
 
 
Slide number  









Major synaptic area  Other features 







A Cl 012414 400.65 488.8 2 8 692 60.9 8 Synaptic area on one arbor 
3-11-13 Cell C 720.1 983 2 14 1243.4 168 11 Synaptic area on major shaft 
B CL 9-26-12 983 577 2 7 1255.2 139.6 7 
Synaptic area on one arbor, 
bidirectional 
9-9-13 Cell B 689.1 613 2 20 +/- 2 1095.4 135.2 15 +/-2 Synaptic area on both arbor 
A CL 9-24-12 413.5 479.5 3 24 700 130.245 18 Synaptic area on one arbor 
8-29-2013 Cell B 475.5 919 2 13 1107.8 149.5 13 Synaptic area on both arbor 
8-29-13 Cell A 
(branch at the 
end) 
649.7 924 2 23 1423.4 193.4 20 
Synaptic area on major shaft and one 
arbor 
Average ± STD 619±208     16±7   140±41 13±5   
 
Table 1.1.2. Morphological Analysis of seven multiple arbor type II afferents. 
 
3. Somata of type II neurons 
The biocytin fills also enable labeling of somata of type II neurons in the spiral 
ganglion. Examples of six type II neurons are shown in Figure 1.1.9. One of them 
showed a typical peudounipolar morphology, which has a bifurcating axon with branches 
going in opposite directions, one centrally and one peripherally. The rest of them (5 cells) 
seem to adopt a bipolar morphology, with one central and one peripheral branch directly 
linked with the soma. However, it is also possible that they could be peudounipolar cells 
viewed from different angles. The central and peripheral processes are similar in diameter, 
consistent with previous reports (Berglund and Ryugo, 1986; Kiang et al., 1982) 
 
Figure 1.1.9. Somata of six different type II neurons in the apical coil of young rats, 
showing peudounipolar or bipolar morphology. Scale bar: 50µm. 
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1.2 Synaptic regions of type II afferents 
Since morphological analysis showed no significant differences among any of the 
measurements between single and multiple arbor type II afferents, all the labeled 
afferents (8 single-arbor and 7 multiple-arbor fibers) were grouped together for a 
summary of their features. The number of synaptic branches within the terminal arbors of 
all fibers averaged 16 ± 5.5 (SD, n = 15). These synaptic branches had an average length 
of 10.88 ± 6.48 µm (SD). They tend to cluster (12 ± 4 (SD) branches, forming a major 
synaptic input region that spans a distance of 139 ± 46 (SD) µm (n=15) with smaller 
secondary clusters 100 µm or more distant in some cases.  The secondary synaptic region 
usually had fewer synaptic branches compared to the major region. In one special case of 
the eight ‘single arbor’ fibers, two synaptic zones 228 µm apart were nearly equal (12 
and 8 branches).  
When examining the detailed morphology using confocal microscopy, we found 
that each synaptic branch not only has a terminal bouton at the end (Figure 1.2.1, white 
arrowhead), but also contains en passant swellings along the thin synaptic branch (Figure 
1.2.1, red arrow). Each branch had an average of 2.04 ± 0.7 (SD) en passant swellings in 
addition to the terminal bouton. Each branch contacted 1-3 OHCs in the same row and 
the average number of OHCs contacted by each type II fiber was 23.71 ± 5.82 (SD). 
Some branches showed arching shapes (Figure 1.2.1, bottom images), that could 




Figure 1.2.1. Higher magnification of synaptic branches. Bottom images are expanded 
boxed area. Red arrows indicate en passant swellings and white arrowhead shows the 
terminal bouton. 
 
The location of the major synaptic input zone ranged from 700 to 1600 µm 
(average 1167 ± 280 µm; SD, n = 15 fibers) from the cochlear apex, placing the synaptic 
area in a frequency range of ~ 9 kHz (Muller, 1991a; Muller, 1991b). On the other hand, 
the 90 degree turning point of the fibers was located at 500 to 1000 µm (average 742 ± 
213 µm; n = 15 fibers) from the apex, placing it in the frequency range of 7 kHz. Thus, as 
noted previously (Brown, 1987), type II afferents, if sufficiently sensitive, would report 
vibrations one quarter to one half an octave higher in frequency than type I afferents 
projecting in parallel to the same tonotopic zone of the cochlear nucleus.   
Besides the synaptic branches contacting OHCs, some small branches were also 
observed as type II afferents bypassed inner hair cells or traveled under the supporting 
cells (Deiters’ cells). These branches however looked very different from a typical 
synaptic branch seen in type II afferents. They were much shorter, and without any 
terminal or en passant swellings (Figure 1.2.2). Another interesting observation was 
made by accidentally labeling two neighboring type II afferents in the same tissue (Figure 
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1.2.3).  Radial processes of these two afferents seemed overlapping and projected 
together to the same tonotopic region of the cochlea. In the spiral ganglion, the two type 
II neurons were located close to each other. Their 90 degree turning points shared a 
similar location. Although they sometimes switched to different rows at the apical portion 
of the spiral process, they finally targeted the same row of OHCs at their terminal region. 
However, their synaptic input regions were neighboring but non-overlapping. One of 
them terminated more apically, forming a clustered synaptic region (Figure 1.2.3.B white 
arrowhead). The other fiber extended further and gave off synaptic branches in a wider 
region more basally (Figure 1.2.3.B black arrows). Although more repetition is needed, 
this suggests that type II afferents project to similar frequency regions and can form 
synaptic contacts with neighboring but non-overlapping sets of OHCs. 
 






Figure 1.2.3. Differential synaptic regions of two neighboring type II afferents. A. Two 
neighboring type II afferents turn at a similar location. B. Higher magnification of the 
synaptic regions. White arrowhead: clustered synaptic region for one fiber. Black arrow: 





To associate the tonotopic location of type II afferents with their morphological 
features, I plotted the measured parameters in Table 1.1.1 and Table 1.1.2 against the 
distance from fiber turning point to apex (Figure 1.2.4). It seems that at more apical 
regions, the length of the spiral process was more variable (Figure 1.2.4 A). A similar 
observation was made for the number of total synaptic branches (Figure 1.2.4 B), in that 
apical fibers have a more variable number of morphological synapses. The location of the 
major synaptic area, measured by the distance from the cochlear apex to the most apical 
synaptic branch of the area, has a positive correlation with the tonotopic location (turning 
point) of the afferent (Figure 1.2.4 C). This reflects that the relative distance between the 
turning point and the major synaptic region is quite stable. There seems to be a weak 
positive correlation between the length of the major synaptic area and the location of the 
fiber for single-arbor afferents, but this trend was not observed in multiple-arbor afferents 




Figure 1.2.4. Morphological features plotted against the location of the type II afferents, 
measure by the distance from apex to their turning point. Data include seven single-arbor 
afferents and seven multiple-arbor afferents in Table 1.1.1 and Table 1.1.2. 
 
Discussion: 
Morphological characterization of type II afferents has been done by studies on 
young and adult animals of many species, including mouse, rat, cat and guinea pigs 
(Berglund and Ryugo, 1987; Brown, 1987a; Echteler, 1992; Ginzberg and Morest, 1983; 
Ginzberg and Morest, 1984; Huang et al., 2007b; Koundakjian et al., 2007; Liberman et 
al., 1990; Perkins and Morest, 1975; Simmons and Liberman, 1988a; Simmons and 
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Liberman, 1988b). The contact between type II afferent and OHC has been described as a 
discrete bouton in some studies ((Ginzberg and Morest, 1984; Nadol, 1983), but can be 
more extensive, forming en passant synapses as it travels past the OHC (Francis and 
Nadol, 1993; Nadol, 1988; Sobkowicz et al., 1993). We found that such en passant 
synapses likely occur in the form of en passant swelling on the fine synaptic branches, 
forming a chain of possible postsynaptic sites together with the terminal bouton.  The 
average number of OHCs contacted by each type II fiber was 23.71 ± 5.82 counted in our 
experiments. This number is similar to that predicted to be required for threshold 
stimulation of type II afferents (Weisz et al., 2012). 
Although we focused only on the apical coil of the cochlea, small differences of 
recording site revealed that type II afferents located more apically tended to be more 
variable in morphology compared with those closer to the middle turn. It has been 
reported that apical type II afferents have more elaborated patterns of innervation, 
whereas middle fibers are the longest and have larger synaptic areas. Synapses of the 
basal type II afferents were found to have more terminal bouton instead of en passant 
swellings (Brown, 1987a; Fechner et al., 2001; Simmons and Liberman, 1988a). It may 
be interesting to address such differences in synaptic transfer by recording type II 
afferents at varying cochlear locations.  
All the HRP stainings were done post-hoc, after the electrophysiological 
experiments described in later chapters. This enabled us to confirm the successful 
recording on type II afferents, and have a better understanding about the morphology of 
the recorded cells. The finding that the recording site is always located at the distal end of 
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the fiber helped us designing the experiments. For example, for cell ablation studies, 
OHCs apical to the recording sites should be situated right above the recorded fibers. And 
to record the synaptic inputs from OHCs to type II afferents, the location of recording 

















Chapter 2: Postsynaptic receptors of type II afferents 
In the mammalian cochlea, inner hair cells release glutamate to excite AMPA-
type receptors (AMPARs) on the predominant (95%) type I afferents (Glowatzki and 
Fuchs, 2002; Ruel et al., 2000) that provide all acoustic input to the brain. The synaptic 
arrangement of type I afferents with IHCs has been well-characterized. In particular, the 
single dendrite of each type I afferent forms a compact bouton ending opposite to a 
presynaptic ribbon of the IHC (Ginzberg and Morest, 1984; Hafidi et al., 1990; Khimich 
et al., 2005; Kiang et al., 1982; Liberman et al., 2011; Wang and Green, 2011). In 
contrast, connections between individual type II afferents and OHCs remain to be fully 
elucidated. In particular, it is not known whether ribbon synapses comprise the main or 
the only sites of signaling, since non-ribbon-associated contacts between OHCs and type 
II afferents were reported (Dunn and Morest, 1975; Nadol, 1983).  Recently it has been 
suggested that AMPA receptors may also mediate outer hair cell transmission to the scant 
and enigmatic type II afferents (Glowatzki and Fuchs, 2002; Weisz et al., 2009). 
However, the pharmacology used was AMPA/kainate receptor antagonist – NBQX, and 
this could not rule out the role of kainate receptors present at this synapse found by 
immunolabel (Fujikawa et al., 2014). The physiological result also runs counter to the 
conclusion, based on immunolabeling of GluA2/GluA3 and GluA2 subunits, that OHC 
synapses are not AMPAR-dependent (Chen et al., 2009; Flores-Otero and Davis, 2011; 
Khimich et al., 2005; Liberman et al., 2011; Matsubara et al., 1999). More recently it has 
been reported that antibodies to GluA2 label type II contacts to OHCs in the immature 
but not adult rat cochlea (P8), and that the adult synapse may be mediated only by kainate 
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receptors (Fujikawa et al., 2014). Thus, the present study was undertaken to explore this 
issue further and to elucidate the relationship between ribbons, postsynaptic glutamate 
receptors and postsynaptic density markers in afferent fibers at the OHC synapses.  
 
2.1 Type II afferent innervation and synaptic markers 
Additional background 
Unpublished data from my colleague Dr. Rodrigo Martinez Monedero showed for 
the first time that among the 4 subunits of AMPA receptors (GluA1 – GluA4), only anti-
GluA2 produced localized, specific labeling at the OHC regions of excised adult rat 
cochlear whole-mounts. Double labeling with an antibody against CtBP2, a protein found 
in presynaptic ribbons (Lenzi and von Gersdorff, 2001; Wagner, 1997), was performed to 
relate postsynaptic GluA2 labeling to the location of presynaptic ribbons in hair cells 
(Figure 2.1.1). CtBP2 and GluA2 puncta were closely aligned in most cases (Figure 
2.1.1A, magnified inset. Quantification in Figure 2.1.1C). Assuming that the GluA2 
puncta represent functional synapses, this high level of juxtaposition suggests that 
AMPAR-mediated synaptic transmission occurs at ribbon synapses of OHCs, with 2-3 
such ribbon synapses per OHC. As a positive control, GluA2 antibody was also tested in 
the inner hair cell region. Many more presynaptic CtBP2-labeled ribbons and 
postsynaptic GluA2 receptor clusters were found among IHCs and they were consistently 
juxtaposed (Figure 2.1.1B. Quantification in Figure 2.1.1D), consistent with previous 
reports regarding the number of synapses per IHC and the close correspondence between 
CtBP2-labeled ribbons and GluA2/3 or GluA2 receptor clusters (Beutner and Moser, 
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2001; Brandt et al., 2003; Fuchs et al., 2003; Khimich et al., 2005; Liberman et al., 2011; 
Meyer et al., 2009; Neef et al., 2007).  
 
Figure 2.1.1. Maximum intensity projections of confocal z-stacks of the medial region of 
the organ of Corti from an adult rat viewed from the endolymphatic surface including 24 
adjacent OHCs and 5 IHCs.   
A. Immunolabel for the presynaptic ribbon marker (CtBP2: red channel). Immunolabel 
for the postsynaptic marker glutamate receptor A2 (GluA2: green channel). Magnified 
inserts: CtBP2  and GluA2 puncta were closely juxtaposed in the X-Y plane. Rotation to 
the Z-X or Z-Y planes reveals spatial displacement between pre- and postsynaptic 
markers.  B. Pre- and postsynaptic immunolabels IHCs as in A.   CtBP2  and GluA2 
immunopuncta were consistently juxtaposed at the IHCs.  Magnified insert in the X-Y 
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plane shows clear separation of pre- and postsynaptic labels. C. Quantification of the 
number and the percentage of juxtaposed CTBP2 and GluA2 puncta in OHCs. In a single 
OHC there was 2.28 ± 0.17 GluA2 puncta and 2.37 ± 0.08 CtBP2 puncta per OHC.  
85.52 ± 5.48% of CtBP2 puncta were juxtaposed to individual GluA2 puncta and 94.86 ± 
1.1% of GluA2 puncta were juxtaposed to CtBP2 puncta . D. Quantification of the 
number and the percentage of juxtaposed CtBP2 and GluA2 puncta in the IHCs. At 
individual IHCs there were 23.3 ± 0.6 GluA2 puncta and 22.4 ± 1.0 CtBP2 puncta. 96.84 
± 1% of CtBP2 puncta were juxtaposed to individual GluA2 puncta and 96.59 ± 1.1% of 
GluA2 puncta were juxtaposed to CtBP2 puncta. 1A-D: n=3-9 independent preparations; 
50 IHCs, 72 OHCs. There were no statistically significant differences in number or 
correlation among the immunolabels (one way-ANOVA test; p>0.05). Scale bar is 5 µm 
and 2.5 µm in magnifications. From Martinez-Monodero et al., in preparation.   
 
Further insight into the synaptic arrangements of type II afferent neurons was 
gained using antibodies directed against postsynaptic density proteins PSD95, Shank and 
Homer.  In the central nervous system, PSD95 participates in synaptic targeting of 
AMPA receptors (Colledge et al., 2000; El-Husseini et al., 2000; Harms and Craig, 2005; 
Hirbec et al., 2003; Ives et al., 2004; Naisbitt et al., 1997; Sheng, 1997). In contrast to the 
near membrane location of PSD95, Shank and Homer serve as postsynaptic density 
organizing proteins that extend further into the cytoplasm to link cytoskeletal components 
(Brandstatter et al., 2004).  Antibodies to these postsynaptic markers were applied to 
cochlear whole mounts and their labeling compared to that of GluA2 clusters and 
presynaptic ribbons at outer hair cell afferent contacts. 
Interestingly, PSD95, Shank and Homer revealed complex patterns that could 
extend several microns along the synaptic pole of the OHC. These postsynaptic structures 
appeared as an irregular cluster or as an interconnected series, like a short ‘pearl chain’ 
(Figure 2.1.2A, B, F, G). PSD95 and Shank immunolabels were closely colocalized 
(Figure 2.1.2A, insets). Homer showed the same clustered patterns as did PSD95 and 
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Shank (Figure 2.1.2D). The pattern of postsynaptic density markers had an especially 
interesting relationship to the CtBP2-labeled presynaptic ribbons, as shown here for 
Shank (Figure 2.1.2B, F).  Most CtBP2-positive ribbons were juxtaposed to Shank, 
PSD95 or Homer (Figure 2.1.2H). However, roughly half of the postsynaptic densities 
had no associated CtBP2 puncta. A similar relationship between GluA2 and postsynaptic 
density proteins were observed, reflecting the strong correspondence between GluA2 and 
CtBP2 immunolabeling (Figure 2.1.1). The number of postsynaptic density protein 
puncta (PSD95, Shank and Homer) was nearly twice the number of CtBP2 or GluA2 




Figure 2.1.2. Confocal z-stack of the OHCs of the medial region of the organ of Corti 
from an adult rat viewed from the endolymphatic surface.  
A. Immunolabeling with the postsynaptic density proteins PSD95 (red channel) and 
Shank (green channel) show an interconnected series of puncta along the base of the 
OHCs. Both PSD95 and Shank puncta are closely coincident (magnification insert, X-Y 
plane).  
B, Immunolabeling with the presynaptic ribbon marker CtBP2 (red channel) and 
84 
 
postsynaptic markers Shank  
C. Immunolabel for CtBP2 and PSD95.  
D. Immunolabel for CtPB2 and Homer.  Magnified inserts  (X-Y plane) in each case 
show more extensive postsynaptic density distribution than presynaptic.  
E. Pre- and postsynaptic immunopuncta at the OHCs. The number of CtBP2 or GluA2 
puncta was significantly smaller than that of postsynaptic density markers (PSD95, 
Shank or Homer) (one way-ANOVA, p = 0.01; Bonferroni’s multiple comparison test; n 
= 3-7; 72-168 OHCs).  
F. Thumbnails of the base of individual OHCs immunolabeled for CtBP2 (red channel) 
and Shank (green channel). Many the Shank immunopuncta had no CtBP2 associated 
with them.  
G. Thumbnails of the base of individual OHCs immunolabeled for GluA2 (red channel) 
and Shank (green channel). Many of the Shank immunopuncta had no GluA2 associated 
with them.  
H. Percent Juxtaposition of the CtBP2 and postsynaptic density proteins. The ratio of 
PSD95, Shank or Homer puncta juxtaposed to CTBP2 was significantly from the ratio of 
CTBP2 puncta juxtaposed to the postsynaptic density proteins (one way-ANOVA test; p ≤ 
0.01; Bonferroni’s multiple comparison test). Scale bar is 5 µm or  2.5 µm in magnified 
inserts and thumbnails.   
I. Schematic drawing of OHC and IHC synapses. At the IHC afferent synapse 
CtBP2/GluA2 relates closely in number to postsynaptic density markers. At the OHC 
afferent synapse, only a subset of postsynaptic density proteins relate to CtBP2/GluA2 
synaptic markers. From Martinez-Monodero et al., in preparation.   
 
Additional Methods 
0.3% biocytin (3.0mg/mL) was added to the intracellular solution of the patch 
pipettes for delivery into the spiral branch of type II afferents via whole-cell gigaohm-
seal recordings. The tracer was detected using streptavidin-conjugated horseradish 
peroxidase, or streptavidin-conjugated fluorescent labeling. In some experiments, the 
cochlear tissue was preloaded (30 second, room temperature) with 5µM FM1-43FX 
(Invitrogen), a fluorescent dye that rapidly enters through mechanotransduction channels 
and partitions into the hair cell membrane. HRP staining was done as previously 
described. In a second set of experiments we combined fluorescent labeling of the fiber 
(biocytin – streptavidin conjugated AF488) with immunofluorescent labeling of synaptic 
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markers in OHCs. The tissue with the filled type II afferent fiber was fixed in 4 % PFA 
for 10-60 minutes at 4°C. Then the tissue was exposed to 1% BSA and 10% heat 
inactivated goat serum in PBS for 1 hour at RT to reduce non-specific labeling. 
Streptavidin-Alexa Fluor 488 conjugate was applied overnight at 4°C in 5% heat 
inactivated goat serum and 1% BSA. Streptavidin-Alexa Fluor 488 conjugate and CtBP2 
or PSD95 antibodies were applied overnight at 4°C in 5% heat inactivated goat serum 
and 1% BSA. Samples were washed and incubated for 1 hour at RT with the secondary 
antibodies (that had been centrifuged at high speed and diluted at 1:1000 in 1xPBS). 
Alexa Fluor 568 goat anti-rabbit and Alexa Fluor 633 goat anti-mouse (Invitrogen) were 
used as secondary antibodies. Samples were rinsed three times for 10 min each in PBS at 
RT before mounting and viewing.   
 
Results 
In order to further relate the synaptic marker proteins with postsynaptic terminals 
on type II afferents, we combined fluorescently labeled biocytin fills of type II afferents 
with immunolabel for pre- and postsynaptic markers CtBP2 and PSD95. Tissue with 
biocytin-filled fibers was treated with streptavidin conjugated Alexa Fluor 488 as 
described in the additional method of this session. Similar to the HRP label shown in 
Chapter 1 (Figure 2.1.3A and B), morphology of fluorescently labeled type II afferents 
was revealed in great detail, clearly showing the structure of the fine synaptic branches 
including a terminal bouton and en passant swellings (Figure 2.1.3C, D, E, F). These 
experiments were done in young rat cochleas (~P8) due to the difficulty of biocytin 
injection in adult cochlea. 
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To locate type II terminals on individual OHCs, we tried two methods to label 
OHCs. In one set of experiments, OHC nuclei were counterstained with DAPI (Figure 
2.1.3C). In a second set of experiments, the tissue was perfused with 5µM FM1-43 for 30 
seconds, a fluorescent dye that is taken up by hair cells through the transduction channel 
(Nishikawa and Sasaki, 1996) (Figure 2.1.3D). The main terminal zone of a filled fiber 
was investigated with confocal microscopy. Again, synaptic branches with bouton 
endings and en passant swellings were visible and branches appeared to arc around the 
synaptic pole of the OHC (Figure 2.1.3C and D, insets). Interestingly, en passant 
swellings and bouton endings together form a structure that resembles the ‘pearl chain’ 
pattern observed for postsynaptic maker proteins (PSD95, Shank and Homer, Figure 
2.1.2). Most of the synaptic branches innervate a single OHC. Occasionally small 
processes could branch or extend to contact multiple OHCs. In this dataset, the number of 
OHCs contacted by one fiber was 23 ± 6.48 (SD, n = 9), identical to the result in 
preparations with unlabeled OHCs counted in the HRP fills (Chapter 1).     
Combination of pre- or postsynaptic immunolabel with fiber filling was only 
occasionally successful.  This may be a result of tissue condition after the time required 
for the intracellular recording protocol, and/or a reflection of less robust expression of 
synaptic proteins in the 8-10 day-old animals needed for successful fiber recording.  In 
any event even this low success rate provides qualitative, if not quantitative description.  
CtBP2 immunopuncta were located near to some, but not all terminal branches as well as 
en passant swellings of a filled fiber (Figure 2.1.3E). One or two CtBP2 puncta were 
associated with multiple swellings on each synaptic branch. The small ratio between 
CtBP2 and the morphological swellings resemble that between CtBP2 and the ‘pearl 
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chain’-like postsynaptic markers (e.g. Shank in Figure 2.1.2F), suggesting these 
morphological swellings may correspond to the postsynaptic structures, and are likely the 
sites for functional synapses. However, when antibody for PSD95 was tested in this 
young age (~P8), not every swelling was colocalized with the postsynaptic marker, 
suggesting the possibility that type II synapses were still under development. Some, but 
not every, terminal branch of a filled fiber could be found in near proximity to juxtaposed 
immunopuncta for CtBP2 and PSD-95 (Figure 2.1.3F), suggesting that more than one 
type II afferent may innervate the same OHC so that the ‘orphan’ CtBP2/PSD-95 cluster 
may be attributed to a different type II afferent that was not filled. Since immunolabel 
proved extremely difficult for filled fiber tissue and this method only allowed fiber filled 
at younger age limited by the recording technique, further immunolabeling was carried 
out on young cochlear whole-mounts (~P8) that were processed similarly to the adult 
tissues to examine possible developmental differences.  Double-immunolabel for CtBP2 
and PSD-95 gave an intermittent ‘pearl chain’ association like that of the adult OHC 
(Figure 2.1.3G), suggesting that some adult features are already present in the cochlear 
synapses of young rats.  Therefore these results may still partially reflect the organization 





Figure 2.1.3. Single type II fibers with intracellular labeling.   
A.  Apical turn of a young (P8) rat organ of Corti with biocytin filled type II fiber after 
Streptavidin-peroxidase reaction. Scale bar  125 µm.   
B. Higher magnification of boxed areas in A – showing trajectory and terminal branches.  
C. Biocytin-filled type II fiber reacted with streptavidin-AlexaFluor488 (green). OHC 
nuclei labeled with DAPI (blue).  Magnifications show en passant (red arrows) and 
terminals (white arrowheads) of branches from boxed regions.   
D. Biocytin-streptavidin-AlexaFluor488 filled fiber combined with FM1-43-labelled 
OHCs (red). Magnifications show terminal branches enwrapping the base of outer hair 
cells.   
E.  Biocytin-streptavidin-AlexaFluor488 filled fiber combined with CtPB2 immunolabel 
(red).  Magnifications show approximation of some terminal branches to CtBP2 puncta.    
F. Biocytin-streptavidin-AlexaFluor488 filled fiber combined with immunolabel for 
CtBP2 (red) and PSD95 (blue).  Magnifications show approximation of some (but not all) 
terminal boutons to juxtaposed pre- and postsynaptic immunopuncta.   
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G. Combined immunolabel for PSD95 (green) and CtBP2 (red) among OHCs of young 
rat cochlea.  Magnification shows ‘pearl chain’ pattern found in adult cochlea.  Scale 
bar 5µm in B, C, D, E, F, G. From Martinez-Monodero et al., in preparation.   
 
 
2.2 AMPA receptors mediate OHC-type II synaptic transmission 
The identity of neurotransmitter and receptors at the OHC to type II contact has 
been debated for some years.  The absence of GluR2/3 immunoreactivity led to the 
conclusion that some mechanism other than AMPAR-mediated transmission operated 
there (Matsubara et al., 1996a; Thiers et al., 2008).  Initial studies of synaptic currents in 
type II afferents showed that these were blocked by the AMPA/kainate antagonist NBQX, 
leaving open the possibility that postsynaptic kainate receptors shown by 
immunohistochemistry study (Fujikawa et al., 2014) might mediate the response to 
glutamate release from OHCs.  On the other hand, our work described here revealed that 
the AMPA receptor subunit GluA2 were present in the outer hair cell region, juxtaposed 
with the CtBP2-labeled ribbons and co-localized with around half of the more extensive 
postsynaptic markers (Martinez-Monedero et al.; in preparation).  
Further support for the involvement of GluA2 AMPA receptors was obtained by 
intracellular recording from type II afferents in excised apical turns of young rat cochlea 
(P7-P9).  The highly potent AMPA-specific noncompetitive antagonist CP-465022 was 
applied while recording potassium-evoked excitatory post-synaptic currents (EPSCs).  
CP-465022 shares a similar binding site on AMPARs with its earlier precedent GYKI, 
but is much more potent on AMPA receptors (Lazzaro et al., 2002; Menniti et al., 2000) 
and highly selective for AMPA over kainite receptors (Lazzaro et al., 2002; Paternain et 
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al., 1995). At 100 µM (2 fibers) and 10 µM (3 fibers) CP-465022 completely eliminated 
EPSCs induced by the elevated external potassium (40 mM) that depolarized OHCs, 
suggesting AMPA receptors mediate the synaptic transmission between OHC and type II 
afferents (Figure 2.2.1A and B).  To further support this observation, CP465022 was 
applied at a lower concentration (1 µM) that partially blocked EPSCs recorded in type II 
afferents (Figure 2.2.1B).  The distribution of EPSC amplitudes was shifted to smaller 
numbers in 1 µM CP465022 (Figure 2.2.1D) compared with control condition (Figure 
2.2.1C). Average EPSC amplitude was reduced to 64.3% and a cumulative plot is shown 
in Figure 2.1.4E (n=2 afferents).  To further probe for kainate or other non-AMPA 
receptors, the residual current in CP-465022 was normalized and its waveform compared 
to that before block. Interestingly, no difference in EPSC kinetics was found before and 
during block by CP-465022 (Figure 2.2.1F). Given the known kinetics differences 
between AMPA and kainite receptors (Lerma and Marques, 2013), our result suggests 
that a single kinetically homogenous population of glutamate receptors is functional at 
this synapse. The relatively fast deactivation kinetics of EPSCs suggests a role for AMPA 
receptors, rather than the normally much slower kainite receptors. 
Inclusion of the GluA2 subunit renders AMPARs impermeable to calcium 
(Hollmann et al., 1991; Mishina et al., 1991), suggesting that synaptic currents in type II 
afferents flow through calcium-impermeant channels. This finding was further supported 
by data from the doctoral thesis of Catherine Weisz. Cat showed that intracellular 
spermine did not cause rectification of the current-voltage relation of EPSCs, indicating 
the presence of the calcium impermeant GluA2 subunit. She also showed that the 
compounds philanthotoxin and Naspm, which cause conductance block of GluA2-lacking 
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AMPA receptors had no effect on EPSCs recorded in type II afferents. Taken together, 
these results suggest that GluA2-containing AMPARs most likely mediate rapid 
glutamatergic excitation at the OHC to type II afferent synapse in the rat cochlea.  
 
Figure 2.2.1. AMPA receptors mediate the synaptic transmission from OHC to type II 
afferents.  
A. Representative trace showing the complete block of EPSCs by 100µM CP465022. Blue 
star indicate an action current occasionally recorded in this fiber. Recordings were made 
in 40mM external potassium to increase EPSC frequency. 
B. Diary plot of EPSCs showing a complete block by 100µM CP465022 and partial block 
by 1µM CP465022.  
C. Distribution of EPSC amplitude in control (n=3 afferents). 
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D. Distribution of EPSC amplitude in 1µM CP465022 (n=3 afferents).  
E. Representative cumulative plot of EPSCs. EPSC amplitudes decreased in the presence 
of 1µM CP465022 (red).  
F. Scaled EPSC waveforms in control (black) and in 1µM CP465022 (red) showing 
similar kinetics  Modified from Martinez-Monodero et al, in preparation. 
 
2.3 Acetylcholine responses of type II afferents 
Besides the OHC to type II afferent synapse, it has been proposed that type II 
afferents may serve as the postsynaptic targets for cholinergic medial olivocochlear 
efferents that innervate the cochlea. Ultrastructural studies suggested that axodendritic 
efferent to type II afferent synapses may be possible (Nadol, 1983; Thiers et al., 2002). 
Although terminal endings of both medial olivocochlear efferents (MOC efferents) and 
type II afferents were clustered at the base of OHCs, morphological synapses between 
MOC efferents and type II afferents were identified on the dendritic ‘shaft’ of outer spiral 
bundle fibers that were further away from their OHC contacts. Evidence for such 
morphological synapses was the appearance of a few vesicles found close to the cell 
membrane on the efferent side. Since the major transmitter released from MOC efferent 
is acetylcholine (ACh) (Eybalin, 1993), we tried to probe if this axodendritic synapse is 
functional by testing ACh responses in type II afferents.  
Whole-cell voltage clamp recordings were made in 5 type II afferents from young 
rat (P7-P10) cochlea. Applying 1 mM ACh consistently induced very small responses (1-
4pA) which were hardly measurable.  When I switched to current clamp recordings, a 
small depolarization by 1 mM ACh was recorded, averaged 2.9 ± 1.7 mV (n=7 cells). 
Figure 2.3.1 shows the biggest ACh induced response recorded in a type II afferents. No 
correlation was found between the response amplitude and the age (within the range of 
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P7-P10) of the animal. Because of the insignificant ACh response at the young ages 
limited by our preparation, this question was not pursued further in this thesis. 
 
Figure 2.3.1. Small ACh responses recorded in a type II afferent from a P9 rat. 
 
Discussion 
The synaptic organization of OHC-type II afferents was poorly understood. 
Although EPSCs triggered by OHC depolarization were recorded in type II afferents, this 
finding was confounded by the lack of immunolabel of GluA2/3 AMPA receptors at this 
synapse (Eybalin et al., 2004; Fujikawa et al., 2014; Knipper et al., 1997b; Liberman et 
al., 2011; Matsubara et al., 1996b; Meyer et al., 2009). Only one study localized very 
weak GluA2/3 puncta in outer hair cells but they were not associated with the presynaptic 
ribbon labeled by CtBP2 (Huang et al., 2012). Non-ribbon-associated contacts between 
OHCs and type II afferents were also reported (Dunn and Morest, 1975; Nadol, 1983). 
Therefore, the type of postsynaptic receptors, as well as whether ribbons serve as the 
major site of synaptic transmission was still controversial. The present work shows that 
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postsynaptic GluA2 expression corresponded highly with the presynaptic ribbons labeled 
by CtBP2, with a nearly 1:1 ratio. Although the PSD-95, Shank and Homer antibodies 
revealed extensive ‘pearl chain’-like postsynaptic densities, the AMPA receptor subunit 
GluA2 was expressed specifically at only two or three spots in the ‘pearl chain’ where a 
presynaptic ribbon was juxtaposed, forming discrete sites of synaptic contacts. The ‘pearl 
chain’-like postsynaptic structures were related to the morphological swellings on type II 
dendrites through biocytin fills. On each synaptic branch of type II afferents, the en 
passant and terminal swellings were also arranged in a chain structure, and the distances 
between these swellings were similar to the distances between puncta of the postsynaptic 
markers. CtBP2 immunolabeling was further found juxtaposed to the swellings on type II 
dendrites, suggesting these are the sites for GluA2-containing AMPA receptor mediated 
synaptic transmission. These findings not only confirmed the previous observation of 
discrete boutons (Ginzberg and Morest, 1984; Nadol, 1983) or more extensive, en passant 
synapses between OHC and type II afferents (Francis and Nadol, 1993; Nadol, 1988; 
Sobkowicz et al., 1993), but also associated these morphological features with a highly 
specialized organization of pre- and postsynaptic proteins. 
Our electrophysiological experiments suggest that synaptic transmission is most 
likely mediated by GluA2-containing AMPA receptors. CP-465022 has been shown to 
serve as a selective antagonist for AMPA over kainate or NMDA receptors (Lazzaro et 
al., 2002). The concentration used in our experiments (1, 10, 100 µM) has a minimal 
effect on GluK2 receptors tested by heterologous expression in Xenopus oocytes 
(Balannik et al., 2005). Analysis of EPSC waveforms before and after partial blocks 
(Figure 2.2.1F) suggests that synaptic currents were contributed by a single kinetic group, 
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which is faster than the typical kainate receptor mediated EPSCs identified in other native 
neurons (Lerma and Marques, 2013). Together with the pharmacological experiments on 
calcium permeant and impermeant AMPARs, this evidence further supports the presence 
and function of GluA2-containing AMPARs at OHC-type II afferent synapses. 
It was intriguing to identify ‘empty slots’ on the extensive postsynaptic densities 
on type II afferents. These slots were revealed by antibodies to postsynaptic proteins, but 
were negative for ribbon (CtBP2) and AMPA receptors (all of the subunits GluA1-A4 
were tested). One possibility is that these ‘empty slots’ are not completely free of 
receptors, but can be occupied by postsynaptic receptors other than the AMPARs. 
Kainate receptors had been colocalized to a similar postsynaptic density structure (named 
‘C shape’) identified in type II afferents (Fujikawa et al., 2014) and immunogold labeling 
of P2X2 receptors was found at the OHC-type II synapse (Housley et al., 1999). It is 
unclear if NMDA receptors and metabotropic glutamate receptors are present at this 
synapse. However, our physiological studies showed that EPSCs recorded in type II 
afferents were most likely mediated by GluA2-containing AMPARs. These results did 
not reveal any residual components of EPSCs that might be mediated by other receptors. 
Therefore even if other receptors coexist at the same synapse, they might be playing a 
modulatory role instead of directly contributing to the synaptic currents. A second 
possibility is that such ‘empty slots’ may be sites of silent synapses that allows plasticity 
to occur. It would be interesting to examine this hypothesis and investigate what kind of 




Chapter 3: Purinergic signaling in type II afferents 
Although synaptic inputs from OHCs have been recorded and carefully 
characterized (Weisz et al., 2009; Weisz et al., 2012), whether acoustic stimulation of 
outer hair cells could serve as the adequate stimulus for type II afferents is still a 
remaining question. Sound drives OHCs and the depolarization could reach ~0mV 
(Johnson et al., 2011). However, tested in vivo, broad band sound could not activate type 
II afferents, whereas the same condition faithfully triggered responses of type I afferents 
(Brown, 1994; Robertson, 1984; Robertson et al., 1999). The lack of sound-driven 
responses of type II afferents may be explained by the weak synaptic transfer function. 
Release probability of OHCs was low so that each action potential has ~1/4 chance to 
trigger single vesicular release,  which causes a small EPSP (3.8±2.0 mV) compared to 
the action potential threshold (~25 mV from the resting membrane potential). Even 
though each type II afferent connects with over ten OHCs and summation of EPSPs is 
likely, by calculation, synaptic activation of type II afferents is difficult, unless loud or 
even traumatic level of sound maximally activates all the presynaptic OHCs (Weisz et al., 
2009; Weisz et al., 2014; Weisz et al., 2012). 
Another phenomenon accompanying loud sound stimulation is the increased 
concentration of ATP in the cochlear fluid (Munoz et al., 1995). ATP strongly 
depolarized type II afferents and elicited action potentials in extracellular recordings. 
Although some EPSCs were also recorded, the large slow component of the ATP-
triggered responses in type II afferents was unchanged when synaptic transmission was 
blocked, suggesting that such response was intrinsic to the type II afferents and was 
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independent of synaptic transmission (Weisz et al., 2009). It was speculated that the 
sensitivity to ATP might enable robust responses of type II afferents during acoustic 
damage. However, purinergic signaling in type II afferents was poorly understood and it 
was unclear which receptors mediated the responses. In this chapter, we investigated the 
types of purinergic receptors expressed in type II neurons, and revealed both ionotropic 
and metabotropic components of ATP and UTP induced responses. 
 
3.1 Characterization of the ionotropic P2X receptors 
In order to examine the presence of the ionotropic P2X receptors, 50 µM ATP 
was applied using a large-bore gravity-driven application pipette. For all the experiments, 
the application pipette was positioned parallel to the cochlear spiral so that perfusion 
could cover a longer distance of the type II afferents’ spiral dendrites. Inward current was 
induced in type II afferents by ATP, averaging 55.3±17.7 pA at peak (voltage clamp at -
60 mV, 10 experiments in 7 afferents) and a large depolarization could also be recorded 
in current clamp recordings (Figure 3.1.1 A and B). The ATP evoked response was 
significantly reduced by the P2X antagonist, PPADS (Fig. 3.1.1 A, 3.5±3.4 pA, p < 0.05, 




Figure 3.1.1. ATP evoked inward current and depolarization in type II afferents.  
A. ATP induced current can be blocked significantly by the P2X receptor antagonist 
PPADS (red trace), with partial recovery (blue trace). 
B. 50 µM ATP induced a large depolarization in type II afferents. 
 
PPADS is a known P2X receptor antagonist, but it also partially blocks P2Y4 and 
P2Y6 receptors. To further test the contribution of P2X receptors to the ATP-induced 
responses in type II afferents, a voltage ramp protocol was employed to unveil the ionic 
mechanism. Holding potential was ramped from -90mV to +30mV in normal external 
solution or after 50 µM ATP was applied (Figure 3.1.2 A and B).  Ramp current in the 
absence of ATP (Figure 3.1.2 B, black) was subtracted from that in its presence (Figure 
3.1.2 B, red) to obtain the ATP-dependent ramp current (Figure 3.1.2 C). After 
subtraction, the resulting ATP-dependent current showed an inward current upon ATP 
application, and went outward when voltage was ramped to positive values (Figure 3.1.2 
C). The ATP-dependent current–voltage (I-V) relation had a positive slope at its reversal 
near 0 mV (Figure 3.1.2D, representative of 5 experiments in 3 cells), consistent with the 
activation of non-selective cation channels (P2X receptors). This non-selective 
conductance induced by 50 µM ATP further supports the presence of P2X receptors in 




Figure 3.1.2. I-V relation of ATP response revealed by voltage ramp in voltage clamp 
recordings. A. Voltage command. 
B. Overlay of responses from a type II afferent when the holding potential was ramped 
from -90mV to +30mV in normal external solution (black), or after ATP was applied 
(red). Inset: expanded trace during voltage ramp with (red) and without (black) ATP 
application.  
C. Subtracted response in B, showing the ATP-dependent component.  




3.2 Characterization of the metabotropic P2Y receptors 
Next we examined the presence of the other class of purinergic receptor – the 
metabotropic P2Y receptor. UTP (100 µM), an agonist of P2Y2, P2Y4 and P2Y6 
receptors, evoked a small inward current in voltage-clamp at -60 mV (8.9 ± 4.7 pA, 12 
experiments in 8 cells, Figure 3.2.1A). Similarly, in current clamp recordings, 100µM 
UTP caused a much smaller depolarization (6.8 ± 4.4 mV, n=11 afferents, Figure 3.2.1B) 
than that induced by 50 µM ATP. The difference in the size of the responses implied that 
UTP might trigger a distinct ionic mechanism. 
 
Figure 3.2.1. UTP (agonist for P2Y2, P2Y4 and P2Y6 receptor) induced inward current 
and depolarization in type II afferents.   
A. UTP-evoked inward current in voltage clamp recordings at -60mV. EPSCs (the 
downward ‘spikes’) were occasionally recorded, but their frequency was not changed 
significantly during UTP application. 
B. UTP-evoked depolarization was smaller on average than that due to ATP. 
 
The I-V relation of UTP-evoked current revealed a decrease in potassium 
conductance by P2Y receptor activation. Tested by a similar voltage ramp protocol 
(Figure 3.2.2 A and B), the UTP-dependent ramp current was distinct from the ATP-
dependent ramp current, with an opposite direction during the voltage ramp (Figure 3.2.2 
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C). The UTP-dependent current was entirely inward, activating positive to -70 mV (Fig. 
3.2.2 D, representative of 6 experiments in 6 cells), and the reversal potential can be 
extrapolated to near EK, suggesting the closure of voltage-dependent potassium channels 






Figure 3.2.2. I-V relation of UTP response revealed by voltage ramp in voltage clamp 
recordings. 
A. Voltage command. 
B. Overlay of responses from a type II afferent when the holding potential was ramped 
from -110mV to +30mV in normal external solution (black), or after UTP was applied 
(blue). Inset: expanded trace during voltage ramp with (blue) and without (black) UTP 
application.  
C. subtracted responses in B, showing the UTP-dependent component.  




Responses to UTP in type II afferents suggest the involvement of P2Y2, P2Y4 or 
P2Y6 subunits. Among them, P2Y2 and P2Y4 receptors could also be activated by ATP. 
However, the I-V relation of 50 µM ATP induced current only reflected a P2X receptor-
mediated nonselective cation conductance (Figure 3.1.2 D). We found that this may be 
explained by the differential affinity of P2X and P2Y receptors for ATP. I-V relation of 
ATP responses in type II afferents showed a transition from ‘P2X-like’ to ‘P2Y-like’ 
behavior when ATP concentration was gradually lowered (Figure 3.2.3). With the lowest 
concentration tested (1µM), the ATP-dependent ramp current was inward at positive 
voltages (i.e., reduced outward current) and resembled the I-V relation of UTP responses, 
suggesting that P2Y receptors may be preferentially activated. With increasing 
concentration, the ATP-evoked current became more inward at negative voltages, and 
less so at positive voltages, suggesting the P2X response (increased cation conductance) 
overwhelms the P2Y response in higher concentrations of ATP (n=2 afferents). Therefore, 
it seems that the relative contribution of P2X and P2Y-KCNQ pathways depends on the 
local ATP concentration on type II afferents. At sub micro-molar ATP, the higher-affinity 
P2Y-KCNQ pathway is preferentially activated.  At higher concentrations of ATP the 




Figure 3.2.3. Low concentrations of ATP preferentially activate ‘P2Y-like’ ramp currents.   
A voltage-ramp protocol (as in Fig. 3.2.2) was used to examine membrane currents 
evoked in type II fibers by lower concentrations of ATP (1 µM, 5 µM and 10 µM) that 
might differentially activate lower (P2X) and higher affinity (P2Y) receptors.  As ATP 
concentration was decreased the evoked ramp current changed from ‘P2X-like’ to ‘P2Y-
like’. With the lowest concentration tested (1 µM), the ATP-dependent current was 
inward at positive voltages (i.e., reduced outward current), suggesting that P2Y receptors 
may be preferentially activated. With increasing concentration the ATP-evoked current 
became more inward at negative voltages, and less inward at positive voltages, 
suggesting the P2X response (increased cation conductance) overwhelms the P2Y 
response in higher concentrations of ATP (2 experiments in 2 cells). 
 
3.3 P2Y receptor activation closes KCNQ potassium channels 
The potassium conductance closed by UTP reflected voltage dependency at 
positive voltages (Figure 3.2.2 D), suggesting that the signaling pathway involved 
voltage-gated potassium channels inhibited by metabotropic receptors. A good candidate 
is the KCNQ (Kv7) family potassium channels that can be regulated by the Gq-PLC 
pathway. The KCNQ channel antagonist XE-991 reversibly eliminated the UTP-
dependent ramp current in type II afferents (Figure 3.3.1A, from 92.7±20.8 to 3.8±4.5 pA, 
at +40 mV, 4 experiments in 4 cells, p<0.01), and the KCNQ channel opener retigabine 
reliably activated outward currents (Figure 3.3.1B, 37.9±3.0 pA at -60 mV, 4 experiments 
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in 4 cells).  These effects suggest that P2Y receptor activation depolarized type II 
afferents through the closure of KCNQ channels. This is consistent with the small effect 
of UTP at -60mV (Figure 3.2.1A) where few voltage-dependent KCNQ channels are 
open.   
The closure of KCNQ channels by P2Y receptors increased type II fiber 
excitability. In UTP, the current threshold for type II afferent action potentials was 
reduced to 78.2 ± 3.5% of the level required in normal conditions (four experiments in 
four cells; P < 0.01) (Figure 3.3.1C). Thus, UTP caused a small, but significant increase 
in excitability, despite the fact that these measurements were made at rest where only few 
KCNQ channels are open (Figure 3.2.2 D). The effect of P2Y-mediated KCNQ closure 
will be greater still when type II afferents are depolarized as during acoustic trauma. Thus, 





Figure 3.3.1. KCNQ channels were closed upon P2Y receptor activation and regulated 
excitability of type II afferents.  
A. XE-991 (KCNQ blocker) reversibly eliminated the UTP-evoked ramp current. I–V 
relation of UTP before (black), during (red), and after (gray) XE-991 application.  
B. Retigabine (KCNQ opener) induced outward current at −60 mV in type II cochlear 
afferents. 
C. Current step protocol (1pA steps) to evoke action potentials (Ci). In UTP, from the 




These results suggest the presence of two distinct purinergic responses mediated 
by ligand gated P2X receptors and G protein-coupled P2Y receptors, respectively. Both 
our pharmacological experiments and the I-V relation studies reflected the P2X receptor 
mediated responses in type II afferents, consistent with the previous finding that PPADS 
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blocked ATP induced spikes (Weisz et al., 2009). The subtype of P2X receptor expressed 
in type II afferents was not further characterized. However, based on the slowly-
desensitizing nature of the ATP responses (Figure 3.1.1 A and Figure 3.1.2 C), the 
subtypes involved might be P2X2, P2X4 or P2X7 receptors, according to a similar slow 
desensitization kinetics of these receptors in heterologous systems (North, 2002) and 
DRG neurons (Burgard et al., 1999; Rae et al., 1998). P2X2 were found to express at the 
postsynaptic terminals of type II afferents by immunogold study (Housley et al., 1999) 
and P2X7 immunolabel was found in SGNs as well as fiber bundles crossing the tunnel 
of Corti (Nikolic et al., 2003). P2X2/P2X3 heteromeric receptors were expressed in 
neonatal rat SGNs confirmed by pharmacology (Greenwood et al., 2007). It is unknown 
if type II and type I afferents express a different set of P2X receptors that may explain 
their difference under physiological and pathological conditions.  Recordings from type I 
terminals revealed quite small ATP induced responses (Tritsch et al., 2007) compared to 
the large depolarization induced by ATP in type II afferents (Figure 3.1.1B). Type I 
afferents were more susceptible to acoustic damage, with swollen terminals and soma 
degeneration after noise exposure (Kujawa and Liberman, 2009), whereas type II 
afferents remained in the damaged cochlea even after the loss of OHCs (Ryan et al., 
1980; Spoendlin, 1971a). Among the purinergic receptors, P2X7 receptor has been 
repeatedly suggested to mediate apoptosis due to its calcium permeability (Ferrari et al., 
1999; Kong et al., 2005) and it might be interesting to examine if this receptor is 
differentially expressed in type I vs type II afferents. 
This was the first demonstration of P2Y receptor mediated responses in type II 
afferents (Figure 3.2.1). Like somatosensory pain fibers, type II afferents rarely fired 
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spontaneous action potentials at rest when tested in vivo (Brown, 1994; Robertson, 1984; 
Robertson et al., 1999). However, when ATP was released during acoustic trauma, P2Y 
receptor closes the KCNQ channels and enhanced neuronal excitability in a similar way 
characterized in many other neuronal types (Brown and Passmore, 2009). This 
mechanism was preferentially activated when the ATP concentration was low (Figure 
3.2.3), consistent with a high affinity of P2Y receptors to ATP (Junger, 2011). The high 
sensitivity of the P2Y-KCNQ mechanism is meaningful considering the long spiral 
dendrites of type II afferents. The closure of potassium channels may make the fiber 
electrically more compact. Even a moderate elevation of ATP concentration might be 
enough to ‘sensitize’ type II afferents and enable them to respond more effectively to 
other stimulation, for example a potentiated synaptic transfer from OHCs, to warn the 













Chapter 4: Damage induced responses in type II 
afferents 
Having established the ATP receptors and signaling pathways in type II afferents, 
we next examined whether type II afferents respond to cell damage using an ex vivo 
preparation. After loud noise exposure, the endolymphatic concentration of ATP rises 2-3 
fold (Munoz et al.; 2001), presumably as a result of damaged cells (e.g. stria vascularis, 
hair cells) and the active release of ATP by supporting cells in the damaged outer hair 
cell region. ATP release also can be induced by mechanical perturbation or hypotonic 
stress without cell damage in vitro (Zhao et al., 2005). In this chapter, we developed a 
method that allows us to record from type II afferents while outer hair cells were ablated 
with a sharp glass probe. We dissected the different components that may contribute to 
the cell damage – induced responses in type II afferents, and tried to address the 
excitability changes after damage. 
 
4.1 Outer hair cell damage activates type II afferents 
To monitor type II afferents, intracellular and extracellular recordings were made 
from their spiral dendrites under OHCs in the apical turn of the cochlea excised from 
young rats [postnatal day 7 (P7) to P10]. As a proxy for cochlear trauma, individual 
OHCs were ruptured with a glass microneedle positioned nearer the cochlear apex than 
the recording electrode. By rapidly advancing the needle, one to three OHCs were 
ruptured (Figure 4.1.1A), visualized by the loss of preloaded FM1-43 fluorescence 
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specifically taken up through hair cells' transduction channels (Meyers et al., 2003) 
(Figure 4.1.1B). The damaged hair cells became round and swollen, and disintegrated 
within a few minutes after rupture. Equivalent but off-center punctures failed to rupture 
hair cells and no change was recorded in type II membrane current or potential, ruling out 
direct mechanical effects of the needle on the type II afferent (Figure 4.1.2B). 
 
Figure 4.1.1. The experimental preparation to study type II afferents’ response to 
damage.  
A. Electrode (Right) recording from a type II afferent (out of focus) under OHC rows 
(stars). The glass needle (arrow) poised to ablate one to three OHCs per trial.  
B. Two FM1-43–loaded OHCs [arrowheads (Bi)] were ruptured and lost fluorescence 
(Bii). 
 
Upon OHC rupture, a large depolarization (23.8 ± 4.5 mV; 14 trials in seven 
afferents) was recorded from type II afferents (Figure 4.1.2A). The depolarization had an 
initial fast phase (rise time 1.36±0.41s), followed by a slow component that lasted tens of 
seconds. Action potentials were triggered on the rising phase of the depolarization 
(Figure 4.1.2A, inset). In voltage-clamp recordings, a long-lasting inward current was 
observed (peak current, 111.9 ± 16.4 pA at −70 mV; 10 trials in six fibers) with a 90% 
decay time of 58.0 ± 9.5 s (Figure 4.1.2B). OHC ablation also faithfully elicited action 
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potentials in loose-patch extracellular recordings (Figure 4.1.2C, n=7 fibers, 23 of 24 
trials induced spikes). The spike trains always appeared within 1s after OHC ablation, 
consistent with the intracellular recording showing action potentials on the rising phase of 
the depolarization (Figure 4.1.2A). 
 
Figure 4.1.2. The cell damage-induced response of type II afferents. Arrow indicates 
OHC damage by the sharp needle. 
A. OHC ablation depolarized type II afferents and triggered action potentials on the 
rising phase (Inset).  
B. Representative traces of damage-induced currents (at −70 mV) from five different type 
II afferents (gray) and the average (black). Identical needle movement that failed to 
ablate OHCs induced no current (magenta).  
C. Loose-patch extracellular recording of type II afferent when OHCs were ablated 
(arrow). Action potentials were reliably generated by hair cell ablation (n=7 fibers, 23 of 
24 trials induced spikes). 
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4.2 ATP from supporting cells contributes to the damage induced response 
A role for ATP in this response was shown by the application of 
pyridoxalphosphate-6-azophenyl-2′,4′-disulfonic acid (PPADS) (50 µM), the P2X 
receptor antagonist that also partially blocks P2Y4 and P2Y6 receptors. The damage-
induced current was greatly abbreviated in PPADS (Figure 4.2.1) (90% decay time, 13.3 
± 7.9 s; P < 0.001 compared with control), and charge transfer significantly decreased 
(from 2.5 ± 0.4 nC in control to 0.8 ± 0.2 nC; P < 0.001). Therefore, ATP mediated the 
slow component of OHC damage induced response in the type II cochlear afferent.  
 
Figure 4.2.1. OHC damage induced response was blocked by PPADS. Average ablation-
induced current in PPADS (red, three trials in three afferents) compared with average 
control current. 90% decay time and charge transfer were significantly decreased. 
 
The prolonged damage-induced response (tens of seconds) is similar in its time 
course to ATP-dependent calcium waves observed in cochlear supporting cells after hair 
cell rupture. These minutes-long waves trigger regenerative ATP release through 
connexin hemichannels on the outer supporting cells, contributing to the rise of ATP 
concentration in the cochlear fluid after damage (Anselmi et al., 2008; Gale et al., 2004; 
Lahne and Gale, 2010; Piazza et al., 2007). Accordingly, when the connexin hemichannel 
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blocker carbenoxolone (CBX) was applied to block ATP release from supporting cells, 
the type II afferent response to hair cell damage was significantly shortened, with a 90% 
decay time of 13.8 ± 2.8 s and charge transfer of 0.8 ± 0.1 nC (Figure 4.2.2; P < 0.001 for 
both measures compared with control), suggesting supporting cells as a major source of 
ATP acting on type II afferents.  
 
Figure 4.2.2. Connexin hemichannel blocker reduced the slow component of damage 
induced response. Average ablation-induced current in CBX(blue, five trials in three 
afferents) compared with average control current. 90% decay time and charge transfer 
were significantly decreased. 
 
4.3 Characterization of other components mediating type II afferent responses to 
damage 
In these experiments, the peak current amplitude in PPADS and CBX was not 
significantly different from that of control responses (Figure 4.2.1 and 4.2.2). This 
residual early peak was responsible for the damage induced action potentials recorded in 
loose-patch extracellular recordings (Figure 4.1.2C), due to the short latency (spikes 
appeared within 1s after OHC damage) and that the spikes were not blocked by PPADS 
(n=2 afferents). To test the possibility that glutamate released from damaged hair cells 
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might contribute to the early peak, a cocktail of glutamate receptor blockers, including 
50µM APV, 50µM CNQX and 1mM MCPG to block AMPA, NMDA, kainate and 
metabotropic glutamate receptors, was perfused into the bath solution prior to outer hair 
cell ablation. However, the cell damage induced responses, reflected by the spike trains in 
extracellular recordings, was not affected by glutamate receptor block (Figure 4.3.1; n=4 
afferents). The average number of spikes produced was 6.94±3.58 per OHC ablation in 
the blocker mixture, not significantly different from 5.53±0.58 spikes per OHC ablation 
in control (p = 0.415). 
 
Figure 4.3.1. Damage-induced responses of type II afferents were insensitive to block of 
glutamate receptors.  
A. Loose-patch extracellular recording of action potentials from a type II afferent 
following OHC ablation (at arrow).  
B. A mixture of glutamate receptor blockers, including 50 µM APV, 50 µM CNQX, and 1 
mM MCPG to block NMDA, AMPA/kainate, and metabotropic glutamate receptors had 
no effect (n = 4 afferents).  
C.Type II response to OHC ablation after removal of glutamate receptor blockers. 
 
A second possibility is that the remaining fast component is caused by the release 
of cytoplasmic potassium from the damaged hair cells. We have taken two approaches to 
test this hypothesis. First, we used ion substitution to change the driving force on 
potassium current. External potassium was elevated from 5.8 to 40 mM by substitution 
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with sodium, shifting the potassium equilibrium (EK) potential from −80 to −31 mV. 
Thus, the effect of any additional potassium released by hair cell damage will be reduced 
in this condition. In normal saline, hair cell rupture might expose nearby tissue to ~150 
mM K
+
, producing an inward current due to the change in EK from −80 to 0 mV. In the 
presence of 40 mM potassium, the same bolus of high potassium will change the driving 
force from −31 to 0 mV. Assuming the induced inward current is purely due to K
+
, the 
evoked current should be 2.6-fold smaller. The peak amplitude of the fast component was 
reversibly decreased 1.7-fold (from 94.1 ± 14.1 to 54.5 ± 5.9 pA; three experiments in 
three afferents) by prior exposure to 40 mM K
+
. Given that the actual changes in 
potassium concentration are unknown, this result supports the suggestion that the early 
inward current is carried at least in part by potassium ions.   
A second approach we took was to puff 150 mM K
+
 saline (110 K-
methanesulfonate, 20 KCl, 0.1 CaCl2, 3.5 MgCl2, 5 K-EGTA, 5 HEPES, 5 
Na2phosphocreatine, 0.3 Tris-GTP, pH 7.2) that does not contain ATP but mimics other 
ionic composition inside of a neuron. In 10 trials in 3 afferents, the maximum response 
induced by puffing internal solution averaged 97.4±6.7 pA (Figure 4.3.2), not 
significantly different from the peak current induced by OHC ablation (Figure 4.1.2 B; 
p=0.103). Taken together, the fast early peak of the cell ablation induced responses might 
due to a rapid potassium depolarization when cells were ruptured, which is probably a 
feature unique to this experimental paradigm, but less likely to happen in vivo because 




Figure 4.3.2. Potassium ions contribute to the peak damage-induced current.  
A. Damage induced responses were decreased in amplitude when the driving force for 
potassium ions was reduced. 
B. Superfusion with “internal solution” (150 mM K-methanesulfonate, buffered calcium, 
no ATP) induced large inward currents in type II afferents.  
 
4.4 Hypersensitivity of type II afferents during damage 
In Chapter 3 we showed that the excitability of type II afferents can be regulated 
by P2Y-KCNQ pathway. During OHC cell ablation, ATP released from supporting cells 
could act on type II afferents for tens of seconds. To address if excitability changes 
during cell ablation, we delivered a series of current injection pulses to test the firing 
threshold of type II afferents at different time points during cell ablation (Figure 4.4.1). In 
117 
 
two afferent recordings, the firing thresholds (measured by the minimum current to 
induce action potentials) were lowered during or even after the cell ablation responses, 
from 10 pA to 5 pA, and from 17pA to 13 pA, respectively. However, due to the 
movement of the sharp needle, the recordings became less stable after cell ablation, 
making the result difficult to repeat when tested in another six type II afferents.   
 
Figure 4.4.1. Type II afferents might become more excitable during OHC damage. The 
same series of current injection steps were delivered before, during and after OHC 
ablation at 100s, to test the excitability changes of type II afferents. 
 
We next tried to assess the role of KCNQ channels directly by pharmacological 
manipulation. The KCNQ activator retigabine (10µM) was applied to the tissue during 
extracellular recordings from type II afferents. OHC damage was used as a means to 
trigger action potentials in type II afferents (Figure 4.4.2 Control). Repeated hair cell 
ablation in the presence of retigabine (KCNQ channel opener) failed to elicit any action 
potentials in five type II fibers (Figure 4.4.2; n=5 afferents), echoing the analgesic effect 
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of retigabine on somatic pain pathways (Brown and Passmore, 2009).
 
Figure 4.4.2. The KCNQ channel activator retigabine reversibly prevented the response 
of type II afferents to OHC ablation (n = 5 afferents).  
 
4.5. Calcium imaging on type II afferents using a cultured preparation. 
The electrophysiological experiments examined the response of one single type II 
afferents at a time. In order to study population responses to cell damage, preliminary 
calcium imaging experiments were conducted on both type I and type II cochlear 
afferents. A Cre line for advillin, an actin regulatory protein of the gelsolin/villin family 
that is expressed almost exclusively in peripheral sensory neurons, was bred into a 
conditional GCaMP3 mouse line, causing expression of the genetically encoded calcium 
sensor in type I and type II neurons. Cochlear explants were dissected out at P5-P7 then 
kept an additional day in culture. Due to the limited availability of the transgenic mice, in 
the initial experiments, female Advillin-Cre mice was crossed with male GCaMP3 mice, 
causing 2/3 of their progeny to express GCaMP3 nonspecifically in all cells. These 
nonspecific expression tissues served as a control to test the cell ablation paradigm. A 
characteristic, long-lasting calcium wave was induced by outer hair cell damage (Figure 
4.5.1A), which propagated in a regenerative way (Figure 4.5.1A; arrow at 70s). The rest 
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of the progeny showed specific labeling of type I and type II afferents as reported 
(Zhang-Hooks et al., 2016). With specific expression of GCaMP3, a type II afferent fiber 
and a type I afferent terminal was found to respond to high potassium stimulation (Figure 
4.5.1B). This “proof of principle” experiment could inform further experiments to 
monitor type II afferents’ activity on a longer time scale, to combine with hair cell 
damage strategies in culture (e.g. ototoxins that kills hair cells), and to address whether 
hypersensitivity occurs after damage. 
 
Figure 4.5.1. Calcium imaging on type II afferents. 
A. Non-selective expression of GCaMP3 in all cells. A sharp needle was targeted on a 
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row-3 OHC (pre). After the OHC was ablated, a regenerative calcium wave was 
observed in outer supporting cells. The wave shrank back the ablation site at 70s, 
indicated by black arrow. 
B. GCaMP3was specifically expressed in type I and type II neurons. High potassium 
solution triggered increased calcium signals in a type II afferent fiber and a type I 
terminal (indicated by the white arrow). Image on the right shows overlay of the 
activated cells with DIC image. 
 
Discussion 
Here we demonstrated that OHC damage could depolarize type II afferents. OHCs 
are among the most sensitive structures in the cochlea that could be damaged by sound 
(Wong and Ryan, 2015). Here cell ablation by a sharp needle was used as a proxy for the 
in vivo damage of OHCs. After the penetration of the sharp needle, OHCs immediately 
became swollen and ultimately ruptured, characteristic for a necrotic death pathway. 
Necrotic death of OHCs was also observed in the noise exposed cochlea (Hu and Zheng, 
2008). Membrane leakage was found 5 minutes after noise exposure, allowing the 
passage of 3kDa and 40kDa membrane tracers (FITC-dextrans). The different aspect of 
noise-induced OHC death is that apoptosis could also occur (Hu et al., 2006; Hu and 
Zheng, 2008; Yang et al., 2004). Following membrane leakage, some OHC nuclei 
became swollen, but other OHCs might have condensed nuclei and their apoptotic death 
was confirmed by TUNEL assay and caspase staining. 
The leakage of OHCs boosted a secondary mechanism that actively released ATP 
from outer supporting cells, making the effect last tens of seconds for each single OHC 
ablation in vitro (Anselmi et al., 2008; Gale et al., 2004; Lahne and Gale, 2010; Piazza et 
al., 2007). Our experiments revealed a similar time course of damage induced responses 
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of type II afferents. ATP contributed up to ~70% of the total charge transfer and elicited a 
long lasting slow response in type II afferents as a result of  only 1-3 OHCs ablation. This 
effect might be greater with noise damage to a large area of the organ of Corti. Tested in 
vivo, ATP concentration was found increased after acoustic damage (Munoz et al., 1995). 
Our study also suggested a role for potassium ions in the damage induced responses of 
type II afferents. In other studies, OHC membrane leakage was observed 5 min after 
noise exposure (Hu and Zheng, 2008) that may lead to potassium ion exit from the cell. 
The endolymphatic potential, maintained by high K
+
 in the endolymph, was also found to 
decrease after noise exposure as a result of a shunting effect (Housley et al., 2013). 
Whether the K
+
 concentration could increase in the perilymph to affect type II afferents is 
unclear. The potassium mechanism may contribute to type II afferents’ response to cell 
damage, but whether this could happen in vivo still needs more investigation.  
Our experiments showed some possible excitability changes of type II afferents 
during cell ablation. In Figure 4.4.1, current steps revealed lowered firing threshold not 
only during the depolarization, but also lasted for tens of seconds after the damage 
induced response. Because of the difficulty of the experiments, this was found in only 2 
out of 8 afferents and needs more experiments to confirm. Retigabine blocked action 
potentials induced by cell damage. However, this may not reflect the excitability changes 
produced by ATP, since the spikes appeared in the early peak whereas the ATP effect 
appeared later as a slow component. To address this effect, a similar experiment applying 
the KCNQ channel blocker XE991 may be more informative to determine the 
physiological influence of the P2Y-KCNQ pathway. 
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Chapter 5: Discussion and Future Work 
This work provides direct evidence that type II afferents, in addition to sensing 
glutamate release from outer hair cells, are activated by cochlear damage in the young 
rat’s cochlea.  This observation may help to resolve the decades-long conundrum that 
type II afferents in vivo are very insensitive to sound (Brown, 1994; Robertson, 1984) and 
yet presumably carry some information to the auditory brainstem.  Likewise, measured ex 
vivo, synaptic excitation is weak and could activate type II afferents only if all the 
presynaptic outer hair cells were maximally stimulated (Weisz et al., 2012).  
Alternatively, ATP potently activates type II afferents (Weisz et al., 2009) and serves as a 
major contributor to the damage-induced response.  Possible enhancement of excitability 
may also lead to robust responses of type II afferents to acoustic stress or cell damage. 
 
5.1 Synaptic structure of OHC-type II afferent synapses 
Although it has been established that OHCs and type II afferents form functional 
glutamatergic synapses (Weisz et al., 2009; Weisz et al., 2012), the identity of the 
postsynaptic glutamate receptor in type II afferents was still controversial. Using 
antibodies against AMPA receptor subunits GluA2/GluA3 or GluA2 alone, most of the 
previous studies failed to reveal immunolabel of AMPA receptors at this synapse 
(Knipper et al., 1997a; Liberman et al., 2011; Matsubara et al., 1996a; Meyer et al., 2009). 
Two recent publications successfully demonstrated GluA2 subunit expression in the OHC 
region (Fujikawa et al., 2014; Huang et al., 2012). However, their results did not suggest 
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a functional synapse mediated by GluA2 receptors. In one study, the GluA2 subunit was 
found associated with presynaptic ribbons in the P8 rat cochlea. However, this is only 
seen in the apical portion but not often in the basal portion, and the labeling was 
completely missing in the adult cochlea (Fujikawa et al., 2014). The basal cochlea is 
known to be more advanced than the apical portion in developmental maturation 
(Waguespack et al., 2007). Therefore, GluA2 expression was interpreted as a transient 
developmental effect since it was only detected in apical cochlea of neonatal rats. A 
second study in mouse cochlea revealed GluA2/GluA3 puncta in OHC region only in 
early postnatal days, however, the expression was permanently lost after P6, also 
revealing a developmental effect (Huang et al., 2012). Using two different antibodies to 
the GluA2 subunit and an improved immunostaining protocol, work from Rodrigo 
Martinez-Monedero in the lab demonstrated juxtaposition of GluA2 and presynaptic 
ribbon marker (CtBP2) in the OHC region, not only in young rat cochlea as previously 
reported, but also in the mature adult cochlea. The labeling was highly correlated with a 
~1:1 ratio, and our work further found CtBP2 puncta were associated with the swellings 
on type II afferents, revealing the site for synaptic transmission at this ribbon synapse. 
The organization of en passant and terminal swellings on the synaptic branches of type II 
afferents corresponded well with the ‘pearl-chain’ like structure of postsynaptic density 
proteins, discovered in this work (Martinez-Monedero et al., unpublished) and previously 
(Fujikawa et al., 2014). AMPA receptor mediated synaptic transmission was further 
supported by the blocking effect of the AMPA specific antagonist CP-465,022, as well as 
the fast kinetics observed for EPSCs, since kainate receptor mediated synaptic currents 
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are normally slow and have a time constant of decay similar to that of NMDA receptors 
(Lerma and Marques, 2013). 
The ‘empty-slot’ on postsynaptic densities of type II afferents leads to an 
interesting hypothesis that plasticity may occur at this normally weak synapse. Within the 
‘pearl-chain’ postsynaptic structure, nearly half of the slots were found without GluA2 or 
CtBP2. The extensive postsynaptic structure with weaker GluA2 immunolabeling, as well 
as less well-organized presynaptic vesicles surrounding the ribbons (Fuchs and Glowatzki, 
2015; Weisz et al., 2012) may explain the much weaker synaptic transmission at OHC-
type II afferents synapse, compared to the efficient IHC-type I afferents synaptic 
transmission (Glowatzki and Fuchs, 2002). The weak synaptic transmission is normally 
insufficient to activate type II afferents, and it may be interesting to study if the empty 
slots provide sites of receptor insertion, enabling experience-dependent changes of 
synaptic strength (for example, before and after acoustic damage). Tightly regulated 
AMPA receptor trafficking in and out of synaptic regions is crucial for synaptic plasticity 
in central neurons, and this process is NMDAR and calcium/calmodulin dependent 
(Anggono and Huganir, 2012; Kerchner and Nicoll, 2008). Currently there is no evidence 
for a role of NMDA receptors in type II afferents, but this may be worth exploring. On 
the other hand, our work demonstrated large responses of type II afferents mediated by 
P2X receptors, and such responses might occur during acoustic trauma. P2X receptors 
could account for substantial calcium entry into the cell upon activation. P2X receptor 
calcium permeability is comparable with that for NMDA receptors and is much higher 
than that for AMPA and kainate receptors (Pankratov et al., 2009). P2X receptors might 
regulate synaptic strength upon brain injury when ATP was released in a pathological 
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condition. The effect is still controversial due to other factors that may play a role in the 
process (Fujii, 2004; Yamazaki et al., 2003; Zhang et al., 2006). Some studies showed in 
central neurons that ATP could promote LTP probably due to the calcium permeability of 
P2X receptors (Sim et al., 2006; Wang et al., 2004), but other studies showed a negative 
effect of P2X receptor activation on LTP (Pankratov et al., 2002). The precise mechanism 
of P2X receptor mediated plasticity change is still elusive. 
 
5.2 Type II afferents as nociceptive fibers 
While synaptic transmission from each OHC triggers single vesicular release and 
causes an average EPSP of only ~4mV (Weisz et al., 2012), direct application of ATP 
strongly depolarized type II afferents (~30mV) that made the fiber cross the firing 
threshold (Weisz et al., 2009). ATP can be released into cochlear fluid after mechanical 
or hypotonic stress (even without outer hair cell ablation) in vitro (Zhao et al., 2005) or 
noise exposure in vivo (Munoz et al., 2001).  ATP concentration increase in the cochlea is 
not only caused by the damage to neural and non-neural structures (Wong and Ryan, 
2015), but also triggers active release of ATP in the organ of Corti by supporting cells. 
Experimental ablation of OHCs was shown to initiate ATP-dependent calcium waves in 
nearby Hensen’s cells that further triggers release of ATP through their connexin hemi-
channels, which lasts for tens of seconds (Anselmi et al., 2008; Gale et al., 2004; Lahne 
and Gale, 2010; Piazza et al., 2007). This enabled a large and long-lasting response 
caused by ATP recorded in type II afferents. Our work is the first to show the coexistence 
of the ionotropic P2X mechanism and the metabotropic P2Y pathway in type II cochlear 
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afferents. P2X2 receptors have been located to the postsynaptic junction in the OHC 
region in adult guinea pig (Housley et al., 1999), and P2Y2 receptors have been identified 
in a small population of spiral ganglion neurons but their identity was not confirmed 
anatomically (Huang et al., 2010).  It may be interesting to further investigate the 
subcellular localization of purinergic receptors in type II afferents. The distribution of 
these receptors may define a ‘nociceptive receptive field’ of type II afferents, that is, the 
frequency range of the cochlea spiral that is monitored by each type II afferent fiber. In 
our experiments, sequential cell ablation started from the 15
th
 OHC apical to the 
recording site which is usually located at the terminal of type II afferents’ spiral dendrite. 
Ablation of these OHCs almost never failed to induce responses in type II afferents, 
indicating that the ‘nociceptive receptive field’ at least covers 15 OHCs from the end of 
the fiber. In one study though, ablation of the 20
th
 OHC failed to induce responses but as 
the sharp needle advanced closer to the recording site, the damage induced responses 




 OHC ablation. It is known that apical to the 
synaptic region, type II afferents traveled at lower levels below the supporting cells with 
distance up to 0.5mm away from the OHC base (Berglund and Ryugo, 1987; Ginzberg 
and Morest, 1983; Perkins and Morest, 1975; Simmons and Liberman, 1988a). This part 
of fiber may not be close enough to sense the damage-induced ATP release or may not 
express the purinergic receptors. Most of the recordings in this study were made on type 
II afferents under row 3 OHCs. It is also unknown if type II afferents under different 
OHC rows may have varying size of damage induced responses, since row 3 is closer to 
the Hensen’s cells region which contains numerous supporting cells with damage induced 
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calcium waves and the potential to release great amounts of ATP (Anselmi et al., 2008; 
Gale et al., 2004; Lahne and Gale, 2010; Piazza et al., 2007). 
Before hearing onset, type I afferents also can be activated by periodic ATP 
released from inner supporting cells of Kolliker’s organ, generating spontaneous activity 
that is crucial for cochlear maturation (Tritsch et al., 2010; Tritsch et al., 2007; Wang et 
al., 2015). This process differs from the ATP-dependent activation of type II afferents in 
many aspects. First, purinergic signaling between inner supporting cells and the sensory 
neurons was only observed during a limited period in the immature cochlea. After the 
onset of hearing (around P12), Kolliker’s organ degenerated and the ATP-driven firing of 
auditory nerves ceased. Second, direct response to ATP was small and insufficent to 
activate type I afferents. Action potentials in type I afferents were triggered indirectly 
through synaptic transmission from activated IHCs (Tritsch et al., 2007; Wang et al., 
2015). In contrast, type II afferents are insensitive to synaptic transmission from OHCs 
but strongly activated by direct effects of ATP. These distinctions suggest that type I and 
type II afferents serve different functional roles. Type I afferents receive inputs from the 
auditory receptor neurons (IHCs) and convey acoustic information, whereas type II 
afferents detect trauma via purinergic sensitivity along more extensive dendrites. This is 
analogous to the somatosensory system that large-diameter, myelinated mechanosensory 
fibers provide analytical sensation, while small-caliber, unmyelinated C-fibers transmit 
pain. Similar to the purinergic C-fibers, type II afferents express P2X receptors and can 
be excited by ATP released during tissue damage (Cook and McCleskey, 2002). Type II 
afferents have low basal activity at normal conditions (Brown, 1994; Robertson, 1984), a 
property shared by nociceptors to respond promptly when algogenic agents are present. 
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Finally, KCNQ channels can serve as a potential target for silencing both type II afferents 
and somatosensory pain fibers (Brown and Passmore, 2009). 
To further strengthen this proposal, it is important to know if type I afferents also 
respond to cell damage, since P2X receptors are expressed in IHCs (Housley et al., 1999; 
Sugasawa et al., 1996) so that ATP released during cell damage might activate type I 
afferents by synaptic transmission from IHCs. However, based on current observations, 
cell-damage induced regenerative calcium wave spread in the OHC region along the 
cochlear spiral, but barely reached the IHC region (Lahne and Gale, 2010). This might be 
due to the separation by the tunnel of Corti that may serve as fluid buffer to attenuate the 
spreading of ATP. This question can be examined by the calcium imaging preparation 
described in Chapter 4. What is certain at this point is that the normally ‘silent’ type II 
afferents (Brown, 1994; Robertson, 1984) may have an increased activity during acoustic 
damage. This imbalance of type II vs type I inputs to the brainstem may underlie 
induction of central plasticity changes in pathological conditions such as tinnitus or 
hyperacusis. 
The activation of P2Y-KCNQ pathway may enhance excitability of type II 
afferents. UTP application reduced the current threshold for spikes to 78.2 ± 3.5% of that 
in normal conditions, therefore the effect was mild under these conditions. This is also 
true for somatosensory fibers. The KCNQ channel blocker XE991 itself did not change 
the membrane potential of primary afferents, showing a minimal effect when the 
afferents were at rest (Rivera-Arconada and Lopez-Garcia, 2006). However, the KCNQ 
effect is greater when cells are depolarized, as when Aδ fibers were activated by thermal 
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or mechanical stimulation (Brown and Passmore, 2009). Therefore the regulation of 
excitability may be manifested when type II afferents are activated during acoustic 
damage or under pathological conditions. Previous studies also reported that sensitivity to 
ATP is reduced in type II afferents after the onset of hearing (Weisz et al., 2009), 
consistent with the fact that loud sound is not usually painful to normal ears.  However, 
purinergic signaling in the cochlea is upregulated after noise exposure (Wang et al., 
2003), raising the possibility that type II afferents become more sensitive after damage, in 
part by increased sensitivity to ATP.   
 
5.3 Function of type II afferents 
Our results demonstrated that type II afferents can be activated by acoustic 
damage. In support of this finding, recent work has shown that damaging sound increased 
activity-dependent c-Fos expression in the granule cell region of the cochlear nucleus 
(Flores et al., 2015), the presumed target of type II afferents in the auditory brainstem 
identified by morphological studies (Benson and Brown, 2004; Brown et al., 1988a; 
Brown and Ledwith, 1990; Brown et al., 1988b; Hurd et al., 1999). In this study, a 
Vglut3-/- mouse line was used to silence the IHC-type I pathway whereas the type II 
afferents pathway may be preserved. However, these mice did not show avoidance to 
noise even with high sound pressure levels that damaged OHCs, therefore inconclusive 
for a role of type II afferents in sensing acoustic trauma (Flores et al., 2015). A previous 
study also showed lack of startle reflexes to sound in Vglut3-/- mice (Seal et al., 2008). 
More effort is needed to find out the proper behavioral paradigm that reveals the function 
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of type II afferent pathway. It also has been suggested that activation of type II afferents 
by noise could drive medial olivocochlear efferents to suppress cochlear sensitivity 
(Froud et al., 2015); although that hypothesis is difficult to reconcile with the fact that 
medial olivocochlear efferents have acoustic tuning and sensitivity similar to those of 
type I afferents (Liberman and Brown, 1986). This conclusion was controversial also 
because the peripherin-/- mice used in this study may affect both type II and type I 
afferents, at least found in early development (Hafidi et al., 1993). A more specific 
marker is desired to isolate the function of type II afferents. 
If type II afferents are nociceptors then that information should reach central 
targets mediating withdrawal, or nocifensive behavior, distinct from the standard auditory 
pathways through inferior colliculus to medial geniculate that serve cognitive hearing.  
Type I and type II axons arborize in parallel to the dorsal and ventral cochlear nuclei in 
the brainstem; but only type II endings are found within the small cell cap and granule 
cell layers that envelope the principal nuclei (Benson and Brown, 2004; Brown et al., 
1988a; Brown and Ledwith, 1990; Brown et al., 1988b; Hurd et al., 1999). Postsynaptic 
targets of type II afferents in this area were identified morphologically but without 
functional evidence. The granule cell domain is thought to be a site for multi-modal 
integration as well as the target of collaterals from olivocochlear efferents (Benson and 
Brown, 1990; Benson and Brown, 2004; Brown et al., 1988b; Brown et al., 1991; Paloff 
and Usunoff, 1992; Shore and Zhou, 2006; Wright and Ryugo, 1996; Zhan and Ryugo, 
2007).  Whether components of the small cell cap or granule cell layers project to central 
pain pathways remains to be determined.  The central pathway for type II afferents could 
be determined by the Cre-dependent virus tracing experiments, using a specific mouse 
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line recently discovered in the lab that labels type II afferents. Such mouse lines also 
enable selective manipulation of type II afferents, either by channel rhodopsin to examine 
their postsynaptic target in the auditory brainstem by electrophysiological recordings, or 
by the chemogenetic tools such as DREADDs (Designer Receptors Exclusively Activated 
by Designer Drugs) to study the behavioral consequence of activating or silencing the 
type II afferent pathway. 
Noise causes cochlear neuropathy and cell death, reducing cochlear output to the 
central auditory pathway (Hickox and Liberman, 2014; Wang et al., 2002). Paradoxically, 
noise exposure has been highly correlated with the ‘gain of function’ auditory pathologies 
(Anari et al., 1999; Auerbach et al., 2014; Ince et al., 1987; Kreuzer et al., 2012), such as 
tinnitus and hyperacusis, where phantom sound is perceived, or loud sound becomes 
painful despite acoustic responses of the auditory periphery is reduced. The elevated 
activity of damage-resistant type II afferents (Ryan et al., 1980; Spoendlin, 1971b), like 
the peripheral sensitization of somatic nociceptors in hyperalgesia(Treede et al., 1992), 
may contribute to the painful perception in hyperacusis or may be responsible for the 
induction of central hyperactivity in tinnitus (Auerbach et al., 2014; Eggermont, 2013). A 
reduction in KCNQ channel activity in central neurons has been shown to be important 
for tinnitus induction (Li et al., 2013), and systematic administration of KCNQ activators 
were found to prevent the development of tinnitus in mice (Kalappa et al., 2015; Li et al., 
2013) where type II afferents might be silenced among other targets.  It will be of interest 
to examine type II fibers in the adult cochlea to determine if synaptic connections, KCNQ 
channel expression, purinergic sensitivity, or other aspects of excitability undergo long-
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term changes after acoustic trauma, which may provide insights for therapeutic targets to 
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